00012616549/302025Q2falsehttp://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationhttp://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationhttp://fasb.org/us-gaap/2024#LongTermDebtCurrenthttp://fasb.org/us-gaap/2024#LongTermDebtCurrenthttp://fasb.org/us-gaap/2024#LongTermDebtNoncurrenthttp://fasb.org/us-gaap/2024#LongTermDebtNoncurrentiso4217:USDxbrli:sharesxbrli:sharesiso4217:USDuti:segmentuti:campusuti:stateuti:leasexbrli:pureuti:locationuti:voteuti:institution00012616542024-10-012025-03-3100012616542024-09-3000012616542025-03-3100012616542025-05-0100012616542025-01-012025-03-3100012616542024-01-012024-03-3100012616542023-10-012024-03-310001261654us-gaap:CommonStockMember2024-09-300001261654us-gaap:PreferredStockMember2024-09-300001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:CommonStockMember2024-09-300001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:PreferredStockMember2024-09-300001261654us-gaap:TreasuryStockCommonMember2024-09-300001261654us-gaap:RetainedEarningsMember2024-09-300001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001261654us-gaap:RetainedEarningsMember2024-10-012024-12-3100012616542024-10-012024-12-310001261654us-gaap:CommonStockMember2024-10-012024-12-310001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:CommonStockMember2024-10-012024-12-310001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001261654us-gaap:CommonStockMember2024-12-310001261654us-gaap:PreferredStockMember2024-12-310001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:CommonStockMember2024-12-310001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:PreferredStockMember2024-12-310001261654us-gaap:TreasuryStockCommonMember2024-12-310001261654us-gaap:RetainedEarningsMember2024-12-310001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-3100012616542024-12-310001261654us-gaap:RetainedEarningsMember2025-01-012025-03-310001261654us-gaap:CommonStockMember2025-01-012025-03-310001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:CommonStockMember2025-01-012025-03-310001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001261654us-gaap:CommonStockMember2025-03-310001261654us-gaap:PreferredStockMember2025-03-310001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:CommonStockMember2025-03-310001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:PreferredStockMember2025-03-310001261654us-gaap:TreasuryStockCommonMember2025-03-310001261654us-gaap:RetainedEarningsMember2025-03-310001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001261654us-gaap:CommonStockMember2023-09-300001261654us-gaap:PreferredStockMember2023-09-300001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:CommonStockMember2023-09-300001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:PreferredStockMember2023-09-300001261654us-gaap:TreasuryStockCommonMember2023-09-300001261654us-gaap:RetainedEarningsMember2023-09-300001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-3000012616542023-09-300001261654us-gaap:RetainedEarningsMember2023-10-012023-12-3100012616542023-10-012023-12-310001261654us-gaap:CommonStockMember2023-10-012023-12-310001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:CommonStockMember2023-10-012023-12-310001261654us-gaap:PreferredStockMember2023-10-012023-12-310001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:PreferredStockMember2023-10-012023-12-310001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001261654us-gaap:CommonStockMember2023-12-310001261654us-gaap:PreferredStockMember2023-12-310001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:CommonStockMember2023-12-310001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:PreferredStockMember2023-12-310001261654us-gaap:TreasuryStockCommonMember2023-12-310001261654us-gaap:RetainedEarningsMember2023-12-310001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-3100012616542023-12-310001261654us-gaap:RetainedEarningsMember2024-01-012024-03-310001261654us-gaap:CommonStockMember2024-01-012024-03-310001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:CommonStockMember2024-01-012024-03-310001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001261654us-gaap:CommonStockMember2024-03-310001261654us-gaap:PreferredStockMember2024-03-310001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:CommonStockMember2024-03-310001261654us-gaap:AdditionalPaidInCapitalMemberus-gaap:PreferredStockMember2024-03-310001261654us-gaap:TreasuryStockCommonMember2024-03-310001261654us-gaap:RetainedEarningsMember2024-03-310001261654us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-3100012616542024-03-310001261654uti:UTIMember2025-03-310001261654uti:ConcordeMember2025-03-310001261654us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2025-03-310001261654us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2025-03-310001261654us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2025-03-310001261654us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2025-03-310001261654us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NotesReceivableMember2025-03-310001261654us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NotesReceivableMember2025-03-310001261654us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NotesReceivableMember2025-03-310001261654us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NotesReceivableMember2025-03-310001261654us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2025-03-310001261654us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001261654us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001261654us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001261654us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberuti:RevolvingCreditFacilityAndTermLoansMember2025-03-310001261654us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberuti:RevolvingCreditFacilityAndTermLoansMember2025-03-310001261654us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberuti:RevolvingCreditFacilityAndTermLoansMember2025-03-310001261654us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberuti:RevolvingCreditFacilityAndTermLoansMember2025-03-310001261654us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2024-09-300001261654us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2024-09-300001261654us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2024-09-300001261654us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2024-09-300001261654us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NotesReceivableMember2024-09-300001261654us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NotesReceivableMember2024-09-300001261654us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NotesReceivableMember2024-09-300001261654us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NotesReceivableMember2024-09-300001261654us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-09-300001261654us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001261654us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001261654us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001261654us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberuti:RevolvingCreditFacilityAndTermLoansMember2024-09-300001261654us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberuti:RevolvingCreditFacilityAndTermLoansMember2024-09-300001261654us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberuti:RevolvingCreditFacilityAndTermLoansMember2024-09-300001261654us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberuti:RevolvingCreditFacilityAndTermLoansMember2024-09-300001261654us-gaap:LandMember2025-03-310001261654us-gaap:LandMember2024-09-300001261654srt:MinimumMemberus-gaap:BuildingAndBuildingImprovementsMember2025-03-310001261654srt:MaximumMemberus-gaap:BuildingAndBuildingImprovementsMember2025-03-310001261654us-gaap:BuildingAndBuildingImprovementsMember2025-03-310001261654us-gaap:BuildingAndBuildingImprovementsMember2024-09-300001261654srt:MinimumMemberus-gaap:LeaseholdImprovementsMember2025-03-310001261654srt:MaximumMemberus-gaap:LeaseholdImprovementsMember2025-03-310001261654us-gaap:LeaseholdImprovementsMember2025-03-310001261654us-gaap:LeaseholdImprovementsMember2024-09-300001261654srt:MinimumMemberuti:TrainingEquipmentMember2025-03-310001261654srt:MaximumMemberuti:TrainingEquipmentMember2025-03-310001261654uti:TrainingEquipmentMember2025-03-310001261654uti:TrainingEquipmentMember2024-09-300001261654srt:MinimumMemberuti:OfficeAndComputerEquipmentMember2025-03-310001261654srt:MaximumMemberuti:OfficeAndComputerEquipmentMember2025-03-310001261654uti:OfficeAndComputerEquipmentMember2025-03-310001261654uti:OfficeAndComputerEquipmentMember2024-09-300001261654srt:MinimumMemberuti:CurriculumDevelopmentMember2025-03-310001261654srt:MaximumMemberuti:CurriculumDevelopmentMember2025-03-310001261654uti:CurriculumDevelopmentMember2025-03-310001261654uti:CurriculumDevelopmentMember2024-09-300001261654srt:MinimumMemberus-gaap:SoftwareDevelopmentMember2025-03-310001261654srt:MaximumMemberus-gaap:SoftwareDevelopmentMember2025-03-310001261654us-gaap:SoftwareDevelopmentMember2025-03-310001261654us-gaap:SoftwareDevelopmentMember2024-09-300001261654us-gaap:VehiclesMember2025-03-310001261654us-gaap:VehiclesMember2024-09-300001261654uti:RightOfUseAssetsForFinanceLeasesMember2025-03-310001261654us-gaap:ConstructionInProgressMember2025-03-310001261654us-gaap:ConstructionInProgressMember2024-09-300001261654srt:MinimumMember2025-03-310001261654srt:MaximumMember2025-03-310001261654uti:OperatingLeaseLeaseNotYetCommencedOneMember2025-03-310001261654uti:OperatingLeaseLeaseNotYetCommencedTwoMember2025-03-310001261654us-gaap:RevolvingCreditFacilityMember2025-03-310001261654us-gaap:RevolvingCreditFacilityMember2024-09-300001261654uti:AvondaleTermLoanMember2025-03-310001261654uti:AvondaleTermLoanMember2024-09-300001261654uti:LisleTermLoanMember2025-03-310001261654uti:LisleTermLoanMember2024-09-300001261654uti:FinanceLeasesMember2025-03-310001261654uti:FinanceLeasesMember2024-09-300001261654uti:VariableRateComponentOneMemberus-gaap:RevolvingCreditFacilityMember2024-10-012025-03-310001261654uti:AvondaleTermLoanMember2024-10-012025-03-310001261654uti:LisleTermLoanMember2024-10-012025-03-310001261654uti:FifthThirdBankMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2022-11-180001261654uti:FifthThirdBankMemberus-gaap:LetterOfCreditMemberus-gaap:LineOfCreditMember2022-11-180001261654uti:FifthThirdBankMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-09-260001261654uti:FifthThirdBankMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-09-262024-09-260001261654uti:FifthThirdBankMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:PrimeRateMember2022-11-182022-11-180001261654uti:FifthThirdBankMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MinimumMember2024-09-262024-09-260001261654uti:FifthThirdBankMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MaximumMember2024-09-262024-09-260001261654uti:FifthThirdBankMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-10-012025-03-310001261654uti:FifthThirdBankMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2025-03-310001261654uti:FifthThirdBankNationalAssociationMemberuti:AvondaleTermLoanMemberus-gaap:SecuredDebtMember2021-05-120001261654uti:FifthThirdBankNationalAssociationMemberuti:AvondaleTermLoanMemberus-gaap:SecuredDebtMember2021-05-122021-05-120001261654uti:FifthThirdBankNationalAssociationMemberuti:AvondaleTermLoanMemberus-gaap:SecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrMember2023-04-032023-04-030001261654uti:FifthThirdBankNationalAssociationMemberuti:AvondaleTermLoanMemberus-gaap:SecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrMember2023-04-030001261654uti:ValleyNationalBankMemberuti:LisleTermLoanMemberus-gaap:SecuredDebtMember2022-04-140001261654uti:ValleyNationalBankMemberuti:LisleTermLoanMemberus-gaap:SecuredDebtMember2022-04-142022-04-140001261654uti:ValleyNationalBankMemberuti:LisleTermLoanMemberus-gaap:SecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrMember2022-04-142022-04-140001261654uti:TermLoanFacilityMember2025-03-310001261654uti:FifthThirdBankNationalAssociationMemberuti:AvondaleTermLoanMemberus-gaap:SecuredDebtMember2023-03-310001261654uti:FifthThirdBankNationalAssociationMemberuti:LisleTermLoanMemberus-gaap:SecuredDebtMember2022-04-140001261654uti:FifthThirdBankNationalAssociationMemberuti:LisleTermLoanMemberus-gaap:SecuredDebtMember2022-04-142022-04-140001261654us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-03-310001261654uti:AvondaleSwapMemberus-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-03-310001261654uti:LisleSwapMemberus-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-03-310001261654us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2025-03-310001261654us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2024-09-300001261654us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsMember2025-03-310001261654us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherAssetsMember2024-09-300001261654us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300001261654us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2025-01-012025-03-310001261654us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2024-10-012025-03-310001261654us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2024-01-012024-03-310001261654us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMember2023-10-012024-03-310001261654uti:FacilityConsolidationMemberuti:CampusLocationConsolidationMember2023-12-050001261654uti:FacilityConsolidationMemberuti:CampusLocationConsolidationMemberuti:UTIMember2023-10-012024-09-300001261654uti:FacilityConsolidationMemberuti:CampusLocationConsolidationMemberuti:UTIMember2024-10-012024-12-310001261654uti:FacilityConsolidationMemberuti:CampusLocationConsolidationMemberuti:UTIMember2025-03-310001261654uti:FacilityConsolidationMemberuti:CampusLocationConsolidationMemberuti:UTIMember2025-01-012025-03-310001261654uti:FacilityConsolidationMemberuti:CampusLocationConsolidationMemberuti:UTIMember2024-10-012025-03-310001261654uti:FacilityConsolidationMemberuti:CampusLocationConsolidationMemberuti:EducationalServicesAndFacilitiesMemberuti:UTIMember2024-10-012025-03-310001261654uti:FacilityConsolidationMemberuti:CampusLocationConsolidationMemberuti:UTIMember2024-01-012024-03-310001261654uti:FacilityConsolidationMemberuti:CampusLocationConsolidationMemberuti:UTIMember2023-10-012024-03-310001261654uti:FacilityConsolidationMemberuti:CampusLocationConsolidationMembersrt:MaximumMemberuti:UTIMember2025-03-310001261654us-gaap:SeriesAPreferredStockMember2024-09-300001261654us-gaap:SeriesAPreferredStockMember2025-03-310001261654us-gaap:SeriesAPreferredStockMember2023-12-180001261654us-gaap:PreferredStockIncludingAdditionalPaidInCapitalMemberus-gaap:SeriesAPreferredStockMember2023-12-182023-12-180001261654us-gaap:SeriesAPreferredStockMember2023-12-182023-12-1800012616542020-12-100001261654us-gaap:RestrictedStockMember2025-01-012025-03-310001261654us-gaap:RestrictedStockMember2024-01-012024-03-310001261654us-gaap:RestrictedStockMember2024-10-012025-03-310001261654us-gaap:RestrictedStockMember2023-10-012024-03-310001261654us-gaap:OperatingSegmentsMemberuti:UTIMember2025-01-012025-03-310001261654us-gaap:OperatingSegmentsMemberuti:ConcordeMember2025-01-012025-03-310001261654us-gaap:CorporateNonSegmentMember2025-01-012025-03-310001261654us-gaap:OperatingSegmentsMemberuti:UTIMember2024-01-012024-03-310001261654us-gaap:OperatingSegmentsMemberuti:ConcordeMember2024-01-012024-03-310001261654us-gaap:CorporateNonSegmentMember2024-01-012024-03-310001261654us-gaap:OperatingSegmentsMemberuti:UTIMember2024-10-012025-03-310001261654us-gaap:OperatingSegmentsMemberuti:ConcordeMember2024-10-012025-03-310001261654us-gaap:CorporateNonSegmentMember2024-10-012025-03-310001261654us-gaap:OperatingSegmentsMemberuti:UTIMember2023-10-012024-03-310001261654us-gaap:OperatingSegmentsMemberuti:ConcordeMember2023-10-012024-03-310001261654us-gaap:CorporateNonSegmentMember2023-10-012024-03-310001261654us-gaap:OperatingSegmentsMemberuti:UTIMember2025-03-310001261654us-gaap:OperatingSegmentsMemberuti:ConcordeMember2025-03-310001261654us-gaap:CorporateNonSegmentMember2025-03-310001261654us-gaap:OperatingSegmentsMemberuti:UTIMember2024-09-300001261654us-gaap:OperatingSegmentsMemberuti:ConcordeMember2024-09-300001261654us-gaap:CorporateNonSegmentMember2024-09-300001261654uti:AccreditingCommissionOfCareerSchoolAndCollegesMemberuti:ConcordeCareerCollegesIncMember2025-03-310001261654uti:CouncilOnOccupationalEducationMemberuti:ConcordeCareerCollegesIncMember2025-03-31

__________________________________________________________________________________________________________

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2025

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to ______

Commission File Number: 1-31923

UNIVERSAL TECHNICAL INSTITUTE, INC.

(Exact name of registrant as specified in its charter)

Delaware

86-0226984

(State or other jurisdiction of
incorporation or organization)

(IRS Employer Identification No.)

4225 East Windrose Drive, Suite 200

Phoenix, Arizona 85032

(Address of principal executive offices, including zip code)

(623) 445-9500

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, $0.0001 par value	UTI	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.


Large accelerated filer ¨			Accelerated filer þ
Non-accelerated filer ¨			Smaller reporting company ☐
			Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No þ

At May 1, 2025, there were 54,406,215 shares outstanding of the registrant's common stock.

UNIVERSAL TECHNICAL INSTITUTE, INC.

INDEX TO FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2025


		Page
		Number
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS		ii

PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements
	Condensed Consolidated Balance Sheets at March 31, 2025 and September 30, 2024 (Unaudited)	1
	Condensed Consolidated Statements of Operations for the Three and Six Months Ended March 31, 2025 and 2024 (Unaudited)	2
	Condensed Consolidated Statements of Other Comprehensive Income for the Three and Six Months Ended March 31, 2025 and 2024 (Unaudited)	3
	Condensed Consolidated Statements of Shareholders’ Equity as of March 31, 2025 and 2024 (Unaudited)	4
	Condensed Consolidated Statements of Cash Flows for the Six Months Ended March 31, 2025 and 2024 (Unaudited)	6
	Notes to Condensed Consolidated Financial Statements (Unaudited)	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	37
Item 4.	Controls and Procedures	37

PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	39
Item 1A.	Risk Factors	39
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	39
Item 3.	Defaults upon Senior Securities	39
Item 4.	Mine Safety Disclosures	39
Item 5.	Other Information	39
Item 6.	Exhibits	40

SIGNATURES		41

Table of Contents

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q and the documents incorporated by reference herein contain forward-looking statements within the meaning of the safe harbor from civil liability provided for such statements by the Private Securities Litigation Reform Act of 1995 (set forth in Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”) and Section 27A of the Securities Act of 1933, as amended (“Securities Act”)), which include information relating to future events, future financial performance, strategies, expectations, competitive environment, regulation and availability of resources and involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. From time to time, we also provide forward-looking statements in other materials we release to the public as well as verbal forward-looking statements.

In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “predicts,” “potential” and similar expressions (including the negative form of such expressions) intended to identify forward-looking statements, although not all forward looking statements contain these identifying words. Forward-looking statements are based on our current expectations and assumptions, do not strictly relate to historical or current facts, any of which may not prove to be accurate. Many factors could cause actual results to differ materially and adversely from these forward-looking statements. Important factors that could cause actual results to differ from those in our forward-looking statements include, without limitation:

•failure of our schools to comply with the extensive regulatory requirements for school operations;

•our failure to maintain eligibility for or our ability to process federal student financial assistance funds;

•the effect of current and future Title IV Program regulations arising out of negotiated rulemakings, including any potential reductions in funding or restrictions on the use of funds received through Title IV Programs;

•the effect of future legislative or regulatory initiatives related to veterans’ benefit programs;

•continued Congressional examination of the for-profit education sector;

•regulatory investigations of, or actions commenced against, us or other companies in our industry;

•changes in the state regulatory environment or budgetary constraints;

•our failure to execute on our growth and diversification strategy, including effectively identifying, establishing and operating additional schools, programs or campuses;

•our failure to realize the expected benefits of our acquisitions, or our failure to successfully integrate our acquisitions;

•our failure to improve underutilized capacity at certain of our campuses;

•enrollment declines or challenges in our students’ ability to find employment as a result of macroeconomic conditions;

•our failure to maintain and expand existing industry relationships and develop new industry relationships;

•our ability to update and expand the content of existing programs and develop and integrate new programs in a timely and cost-effective manner while maintaining positive student outcomes;

•a loss of our senior management or other key employees;

•failure to comply with the restrictive covenants and our ability to pay the amounts when due under our credit agreements;

•the effect of our principal stockholder owning a significant percentage of our capital stock, and thus being able to influence certain corporate matters and the potential in the future to gain substantial control over our company;

•the effect of public health pandemics, epidemics or outbreak, including COVID-19; and

•risks related to other factors discussed in our 2024 Annual Report on Form 10-K filed with the SEC on December 5, 2024 (the “2024 Annual Report on Form 10-K”).

The factors above are not exhaustive, and new factors may emerge or changes to the foregoing factors may occur that could impact our business. We cannot guarantee that any forward-looking statement will be realized. Achievement of future results is subject to risks, uncertainties and potentially inaccurate assumptions. Many events beyond our control may determine whether results we anticipate will be achieved. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated,

Table of Contents

estimated or projected. Among the factors that could cause actual results to differ materially are the factors discussed under Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” You should bear this in mind as you consider forward-looking statements.

Also, these forward-looking statements represent our estimates and assumptions only as of the date of the document containing the applicable statement. Except as required by law, we undertake no obligation to update or revise forward looking statements, whether as a result of new information, future events or otherwise. Thus, you should not assume that our silence over time means that actual events are bearing out as expressed or implied in such forward-looking statements. We qualify all of the forward-looking statements in this Quarterly Report on Form 10-Q, including the documents that we incorporate by reference herein, by these cautionary statements. You are advised, however, to consult any further disclosures we make on related subjects in our reports and filings with the Securities and Exchange Commission (“SEC”).

iii

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value and per share amounts)

(Unaudited)


	March 31, 2025		September 30, 2024
Assets
Cash and cash equivalents	$	95,998	$	161,900
Restricted cash	4,515		5,572
Held-to-maturity investments	39,691		—
Receivables, net	31,240		31,096
Notes receivable, current portion	6,334		6,200

Prepaid expenses	14,058		11,945
Other current assets	6,616		5,238
Total current assets	198,452		221,951

Property and equipment, net	263,716		264,797
Goodwill	28,459		28,459
Intangible assets, net	17,782		18,229
Notes receivable, less current portion	39,972		36,267
Right-of-use assets for operating leases	152,118		158,778
Deferred tax assets, net	4,091		3,563
Other assets	15,853		12,531
Total assets	$	720,443	$	744,575
Liabilities and Shareholders’ Equity
Accounts payable and accrued expenses	$	79,757	$	83,866
Deferred revenue	74,943		92,538
Operating lease liabilities, current portion	21,927		22,210
Long-term debt, current portion	2,779		2,697
Other current liabilities	5,694		3,652
Total current liabilities	185,100		204,963
Deferred tax liabilities, net	4,696		4,696
Operating lease liabilities	140,586		146,831
Long-term debt	91,642		123,007
Other liabilities	4,506		4,847
Total liabilities	426,530		484,344
Commitments and contingencies (Note 14)
Shareholders’ equity:
Common stock, $0.0001 par value, 100,000 shares authorized, 54,489 and 53,899 shares issued, 54,406 and 53,817 shares outstanding as of March 31, 2025 and September 30, 2024, respectively	5		5

Paid-in capital - common	220,900		220,976

Treasury stock, at cost, 82 shares as of March 31, 2025 and September 30, 2024	(365)		(365)
Retained earnings	72,108		38,509
Accumulated other comprehensive income	1,265		1,106
Total shareholders’ equity	293,913		260,231
Total liabilities and shareholders’ equity	$	720,443	$	744,575

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)


	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2025		2024		2025		2024
Revenues	$	207,447	$	184,176	$	408,876	$	358,871
Operating expenses:
Educational services and facilities	102,488		97,488		202,629		189,897
Selling, general and administrative	88,106		75,496		161,916		143,551
Total operating expenses	190,594		172,984		364,545		333,448
Income from operations	16,853		11,192		44,331		25,423
Other (expense) income:
Interest income	1,629		1,427		3,388		3,402
Interest expense	(1,657)		(2,184)		(3,330)		(5,055)

Other income (expense), net	9		119		(26)		333
Total other (expense) income, net	(19)		(638)		32		(1,320)
Income before income taxes	16,834		10,554		44,363		24,103
Income tax expense (Note 12)	(5,388)		(2,767)		(10,764)		(5,927)
Net income	$	11,446	$	7,787	$	33,599	$	18,176
Preferred stock dividends	—		—		—		(1,097)
Income available for distribution	$	11,446	$	7,787	$	33,599	$	17,079
Income allocated to participating securities	—		—		—		(2,855)
Net income available to common shareholders	$	11,446	$	7,787	$	33,599	$	14,224

Earnings per share (Note 16):
Net income per share - basic	$	0.21	$	0.14	$	0.62	$	0.32
Net income per share - diluted	$	0.21	$	0.14	$	0.61	$	0.31

Weighted average number of shares outstanding (Note 16):
Basic	54,383		53,757		54,183		45,048
Diluted	55,442		54,770		55,415		46,050

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE INCOME

(In thousands)

(Unaudited)


	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2025		2024		2025		2024
Net income	$	11,446	$	7,787	$	33,599	$	18,176
Other comprehensive (loss) income:
Unrealized (loss) gain on interest rate swaps, net of taxes	(386)		353		159		(533)
Comprehensive income	$	11,060	$	8,140	$	33,758	$	17,643

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(In thousands) (Unaudited)


	Common Stock			Preferred Stock			Paid-in Capital - Common		Paid-in Capital - Preferred		Treasury Stock			Retained Earnings		Accumulated Other Comprehensive Income		Total Shareholders’ Equity
	Shares	Amount		Shares	Amount						Shares	Amount
Balance at September 30, 2024	53,899	$	5	—	$	—	$	220,976	$	—	(82)	$	(365)	$	38,509	$	1,106	$	260,231
Net income	—	—		—	—		—		—		—	—		22,153		—		22,153
Issuance of common stock under stock-based compensation plans	508	—		—	—		—		—		—	—		—		—		—
Shares withheld for payroll taxes	(169)	—		—	—		(4,332)		—		—	—		—		—		(4,332)
Stock-based compensation	—	—		—	—		720		—		—	—		—		—		720
Issuance of common stock upon exercise of stock options	210	—		—	—		659		—		—	—		—		—		659


Unrealized gain on interest rate swaps, net of taxes	—	—		—	—		—		—		—	—		—		545		545
Balance as of December 31, 2024	54,448	$	5	—	$	—	$	218,023	$	—	(82)	$	(365)	$	60,662	$	1,651	$	279,976
Net income	—	—		—	—		—		—		—	—		11,446		—		11,446
Issuance of common stock under stock-based compensation plans	46	—		—	—		—		—		—	—		—		—		—
Shares withheld for payroll taxes	(5)	—		—	—		(147)		—		—	—		—		—		(147)
Stock-based compensation	—	—		—	—		3,024		—		—	—		—		—		3,024



Unrealized loss on interest rate swap, net of taxes	—	—		—	—		—		—		—	—		—		(386)		(386)
Balance as of March 31, 2025	54,489	$	5	—	$	—	$	220,900	$	—	(82)	$	(365)	$	72,108	$	1,265	$	293,913

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (CONTINUED)

(In thousands) (Unaudited)


	Common Stock			Preferred Stock			Paid-in Capital - Common		Paid-in Capital - Preferred		Treasury Stock			Retained Earnings		Accumulated Other Comprehensive Income		Total Shareholders’ Equity
	Shares	Amount		Shares	Amount						Shares	Amount
Balance as of September 30, 2023	34,157	$	3	676	$	—	$	151,439	$	66,481	(82)	$	(365)	$	5,946	$	2,463	$	225,967
Net income	—	—		—	—		—		—		—	—		10,389		—		10,389
Issuance of common stock under stock-based compensation plans	538	—		—	—		—		—		—	—		—		—		—
Shares withheld for payroll taxes	(178)	—		—	—		(2,054)		—		—	—		—		—		(2,054)
Stock-based compensation	—	—		—	—		1,482		—		—	—		—		—		1,482
Preferred stock dividends	—	—		—	—		—		—		—	—		(1,097)		—		(1,097)
Preferred share repurchase	—	—		(33)	—		—		(3,275)		—	—		(8,341)		—		(11,616)
Preferred stock conversion	19,297	2		(643)	—		63,204		(63,206)		—	—		—		—		—
Unrealized loss on interest rate swap, net of taxes	—	—		—	—		—		—		—	—		—		(886)		(886)
Balance as of December 31, 2023	53,814	$	5	—	$	—	$	214,071	$	—	(82)	$	(365)	$	6,897	$	1,577	$	222,185
Net income	—	—		—	—		—		—		—	—		7,787		—		7,787
Issuance of common stock under stock-based compensation plans	74	—		—	—		—		—		—	—		—		—		—
Shares withheld for payroll taxes	(4)	—		—	—		(65)		—		—	—		—		—		(65)

Stock-based compensation	—	—		—	—		2,353		—		—	—		—		—		2,353


Unrealized gain on interest rate swaps, net of taxes	—	—		—	—		—		—		—	—		—		353		353
Balance as of March 31, 2024	53,884	$	5	—	$	—	$	216,359	$	—	(82)	$	(365)	$	14,684	$	1,930	$	232,613

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands) (Unaudited)


	Six Months Ended March 31,
	2025		2024
Cash flows from operating activities:
Net income	$	33,599	$	18,176
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	16,137		14,186

Amortization of right-of-use assets for operating leases	11,316		10,952


Provision for credit losses	9,554		3,189
Stock-based compensation	3,744		3,835
Deferred income taxes	(476)		(314)


Training equipment credits earned, net	(124)		962
Unrealized gain (loss) on interest rate swaps, net of taxes	159		(533)
Other (gains) losses, net	171		83
Changes in assets and liabilities:
Receivables	(11,258)		(1,641)
Prepaid expenses and other current assets	(4,269)		(4,469)
Other assets	(3,430)		(1,088)
Notes receivable	(3,839)		(4,409)
Accounts payable, accrued expenses and other current liabilities	(3,293)		(1,682)
Deferred revenue	(17,594)		(18,139)
Income tax payable/receivable	3,873		(350)

Operating lease liabilities	(11,185)		(10,139)
Other liabilities	(912)		(274)
Net cash provided by operating activities	22,173		8,345
Cash flows from investing activities:

Purchase of property and equipment	(14,292)		(9,759)
Purchase of held-to-maturity investments	(39,691)		—


Net cash used in investing activities	(53,983)		(9,759)
Cash flows from financing activities:
Proceeds from revolving credit facility	—		20,000
Payments on revolving credit facility	(30,000)		(39,000)

Payment of term loans and finance leases	(1,329)		(1,246)

Preferred share repurchase	—		(11,503)
Payments of preferred stock cash dividend	—		(1,097)
Proceeds from stock option exercises	659		—
Payment of payroll taxes on stock-based compensation through shares withheld	(4,479)		(2,119)

Net cash used in financing activities	(35,149)		(34,965)
Change in cash, cash equivalents and restricted cash	(66,959)		(36,379)
Cash and cash equivalents, beginning of period	161,900		151,547
Restricted cash, beginning of period	5,572		5,377
Cash, cash equivalents and restricted cash, beginning of period	167,472		156,924
Cash and cash equivalents, end of period	95,998		116,099
Restricted cash, end of period	4,515		4,446
Cash, cash equivalents and restricted cash, end of period	$	100,513	$	120,545

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(In thousands)

(Unaudited)


	Six Months Ended March 31,
	2025		2024
Supplemental disclosure of cash flow information:
Income taxes paid (refunds received), net	$	7,652	$	6,185
Interest paid	3,498		5,476

Supplemental schedule of noncash investing and financing activities:
Training equipment obtained in exchange for services	$	570	$	302
Depreciation of training equipment obtained in exchange for services	347		270
Change in accrued capital expenditures during the period	183		(1,786)

Conversion of Series A Preferred Stock	—		63,206

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 1 - Nature of the Business

Universal Technical Institute, Inc., which together with its subsidiaries is referred to as the “Company,” “we,” “us” or “our,” was founded in 1965 and is a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, whose mission is to serve students, partners, and communities by providing quality education and support services for in-demand careers across a number of highly-skilled fields. We offer the majority of our programs in a blended learning model that combines instructor-facilitated online teaching and demonstrations with hands-on labs. We have two reportable segments as follows:

Universal Technical Institute (“UTI”): UTI operates 15 campuses located in nine states and offers a wide range of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute and Marine Mechanics Institute (“MMI”), NASCAR Technical Institute, and MIAT College of Technology (“MIAT”). UTI also offers manufacturer specific advanced training programs, which include student-paid electives, at our campuses and manufacturer or dealer sponsored training at certain campuses and dedicated training centers. Lastly, UTI provides dealer technician training or instructor staffing services to manufacturers. UTI works closely with multiple original equipment manufacturers and industry brand partners to understand their needs for qualified service professionals.

Concorde Career Colleges (“Concorde”): Concorde operates across 17 campuses in eight states and online, offering degree, non-degree, certificate and continuing education programs in the allied health, dental, nursing, patient care and diagnostic fields. The Company has designated campuses that offer degree granting programs as “Concorde Career College” where allowed by state regulation. The remaining campuses are designated as “Concorde Career Institute.” Concorde believes in preparing students for their healthcare careers with practical, hands-on experiences including opportunities to learn while providing care to real patients. Prior to graduation, students will complete a number of hours in a clinical setting or externship, depending upon their program of study. We acquired Concorde on December 1, 2022.

“Corporate” includes corporate related expenses that are not allocated to the UTI or Concorde reportable segments. Additional information about our reportable segments is presented in Note 17.

Our primary source of revenues is currently tuition and fees paid by students. To pay for a substantial portion of their tuition, the majority of students rely on funds received from federal financial aid programs under Title IV Programs of the Higher Education Act of 1965, as amended (“HEA”), as well as from various veterans’ benefits programs. For further discussion, see Note 2 on “Summary of Significant Accounting Policies - Concentration of Risk” and Note 23 on “Government Regulation and Financial Aid” included in our 2024 Annual Report on Form 10-K.

Note 2 - Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, our condensed consolidated financial statements do not include all the information and footnotes required by GAAP for complete financial statements. Normal and recurring adjustments considered necessary for a fair statement of the results for the interim periods have been included. Operating results for the six months ended March 31, 2025 are not necessarily indicative of the results that may be expected for the year ending September 30, 2025. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our 2024 Annual Report on Form 10-K. Certain prior period amounts have been reclassified to conform to the current period presentation.

The unaudited condensed consolidated financial statements include the accounts of Universal Technical Institute, Inc. and our wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

There have been no material changes or developments in our significant accounting policies or evaluation of accounting estimates and underlying assumptions or methodologies from those disclosed in Note 2 of our 2024 Annual Report on Form 10-K.

Note 3 - Recent Accounting Pronouncements

The Financial Accounting Standards Board (“FASB”) and the SEC periodically issue new accounting standards or disclosure requirements in a continuing effort to improve standards of financial accounting and reporting. We have reviewed the recently issued pronouncements and concluded the following new accounting standard updates (“ASU”) or SEC rules apply to us.

Effective in Fiscal 2025

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which provides updates to qualitative and quantitative reportable segment disclosure requirements, including enhanced disclosures about significant segment expenses and increased interim disclosure requirements, among others. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted, and the amendments should be applied retrospectively. This ASU will be effective for our Form 10-K for fiscal 2025 and our Form 10-Q for the first quarter of fiscal 2026. We are currently evaluating the impact this ASU may have on our financial statement disclosures.

Effective in Fiscal 2026

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which provides qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures, among others, in order to enhance the transparency of income tax disclosures, including consistent categories and greater disaggregation of information in the rate reconciliation and disaggregation by jurisdiction of income taxes paid. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments should be applied prospectively; however, retrospective application is also permitted. This ASU will be effective for our Form 10-K for fiscal 2026. We are currently evaluating the impact this ASU may have on our financial statement disclosures.

Effective in Fiscal 2028

In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Topic 220): Disaggregation of Income Statement Expenses, which requires additional disclosure of certain amounts included in the expense captions presented on the statement of operations, as well as disclosures about selling expenses. The ASU is effective on a prospective basis, with the option for retrospective application, for annual periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. Early adoption is permitted for annual financial statements that have not yet been issued. We are currently evaluating the impact this ASU may have on our financial statement disclosures.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 4 - Revenue from Contracts with Customers

Nature of Goods and Services

Revenues across the UTI and Concorde segments consist primarily of student tuition and fees derived from the programs we provide after reductions are made for discounts and scholarships that we sponsor and for refunds for students who withdraw from our programs prior to specified dates. We apply the five-step model outlined in Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers. Tuition and fee revenue is recognized ratably over the term of the course or program offered.

In addition to revenue from tuition and fees, UTI and Concorde derive supplemental revenues from sales of textbooks and program supplies and other revenues from dealer technician training and staffing services to manufacturers. All of these revenues are recognized as the transfer of goods or services occurs. Deferred revenue represents the excess of tuition and fee payments received as compared to tuition and fees earned and is reflected as a current liability in our condensed consolidated balance sheets because it is expected to be earned within the next 12 months.

All of our revenues are generated within the United States. The impact of economic factors on the nature, amount, timing and uncertainty of revenue and cash flows is consistent across our various programs for both the UTI and Concorde segments. See Note 17 for disaggregated segment revenue information.

The following table provides information about receivables and deferred revenue resulting from our enrollment agreements with students:


	March 31, 2025		September 30, 2024
Receivables (1)	$	80,331	$	72,080
Deferred revenue	74,943		92,538

(1) Receivables includes tuition receivables, retail installment contract receivables and notes receivable, both current and long term.

During the six months ended March 31, 2025, the deferred revenue balance included decreases for revenues recognized during the period and increases related to new students who started their training programs during the period.

Note 5 - Investments

In February 2025, we invested a portion of our cash and cash equivalents in short-term investments which primarily consist of corporate and government bonds with a minimum credit rating of A. We had the ability and intention to hold these investments until maturity and therefore classified these investments as held-to-maturity. We recorded these at amortized cost and presented them in “Held-to-maturity investments” on our condensed consolidated balance sheet as of March 31, 2025. As of September 30, 2024, there were no outstanding held-to-maturity investments.

The amortized cost, gross unrealized gains or losses, and fair value of investments classified as held-to-maturity at March 31, 2025 were as follows:


	March 31, 2025
			Gross Unrealized				Estimated Fair
Due in less than 1 year:	Amortized Cost		Gains		Losses		Market Value
Corporate and government bonds	$	39,691	$	3	$	(24)	$	39,670

Investments are exposed to various risks, including interest rate, market and credit risk. As a result, it is possible that changes in the values of these investments may occur and that such changes could affect the amounts reported in the condensed consolidated financial statements.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 6 - Fair Value Measurements

The accounting framework for determining fair value includes a hierarchy for ranking the quality and reliability of the information used to measure fair value, which enables the reader of the financial statements to assess the inputs used to develop those measurements. The fair value hierarchy consists of three tiers:

Level 1: Defined as quoted market prices in active markets for identical assets or liabilities.

Level 2: Defined as inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, model-based valuation techniques for which all significant assumptions are observable in the market or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3: Defined as unobservable inputs that are not corroborated by market data.

Any transfers of investments between levels occurs at the end of the reporting period. Assets measured or disclosed at fair value on a recurring basis consisted of the following:


			Fair Value Measurements Using
	March 31, 2025		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds(1)	$	64,598	$	64,598	$	—	$	—
Notes receivable(2)	46,306		—		—		46,306


Total assets at fair value on a recurring basis	$	110,904	$	64,598	$	—	$	46,306

Revolving credit facility and term loans(3)	90,443		—		90,443		—
Total liabilities at fair value on a recurring basis	$	90,443	$	—	$	90,443	$	—


			Fair Value Measurements Using
	September 30, 2024		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds(1)	$	94,772	$	94,772	$	—	$	—
Notes receivable(2)	42,467		—		—		42,467


Total assets at fair value on a recurring basis	$	137,239	$	94,772	$	—	$	42,467

Revolving credit facility and term loans(3)	121,319		—		121,319		—
Total liabilities at fair value on a recurring basis	$	121,319	$	—	$	121,319	$	—

(1) Money market funds and other highly liquid investments with maturity dates less than 90 days are reflected as “Cash and cash equivalents” in our condensed consolidated balance sheets as of March 31, 2025 and September 30, 2024.

(2) Notes receivable relate to UTI’s proprietary loan program and are reflected as “Notes receivable, current portion” and “Notes receivable, less current portion” in our condensed consolidated balance sheets as of March 31, 2025 and September 30, 2024.

(3) The Credit Facility and Term Loans bear interest at rates commensurate with market rates, and therefore, the respective carrying values approximate fair value (Level 2).

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 7 - Property and Equipment, net

Property and equipment, net consisted of the following:


	Depreciable Lives (in years)	March 31, 2025		September 30, 2024
Land	—	$	25,601	$	25,601
Buildings and building improvements	3-30	166,202		165,667
Leasehold improvements	1-20	95,424		94,473
Training equipment	3-10	117,367		119,171
Office and computer equipment	3-10	37,407		36,454
Curriculum development	3-5	5,431		5,127
Software developed for internal use	1-5	13,045		13,045
Vehicles	5	1,399		1,546
Right-of-use assets for finance leases	15	5,603		5,603
Construction in progress	—	10,602		6,314
		478,081		473,001
Less: Accumulated depreciation and amortization		(214,365)		(208,204)
Property and equipment, net		$	263,716	$	264,797

Depreciation expense related to property and equipment was $7.9 million and $15.7 million for the three and six months ended March 31, 2025, and $7.0 million and $13.8 million for the three and six months ended March 31, 2024.

Note 8 - Leases

As of March 31, 2025, we have facility leases at 29 of our 32 operating campuses, and two non-campus locations under non-cancelable operating or finance leases. Additionally, as part of our growth and diversity strategy, we have signed lease agreements for three new campus locations which are expected to open during fiscal 2026, pending regulatory approvals. During the three months ended March 31, 2025, we recorded the facility lease for the new Concorde co-branded Heartland Dental campus in Fort Meyers, Florida as we took possession to begin our construction. Some of our leases contain escalation clauses and requirements to pay other fees associated with the leases. The facility leases have original lease terms ranging from 5 to 20 years and expire at various dates through 2036. In addition, the leases commonly include lease incentives in the form of rent abatements and tenant improvement allowances. We sublease certain portions of unused building space to third parties, which as of March 31, 2025, resulted in minimal income. All leases, other than those that may qualify for the short-term scope exception of 12 months or less, are recorded on our condensed consolidated balance sheets. As of March 31, 2025, we have entered into two additional facility lease agreements that have not yet commenced with total minimum lease payments of approximately $27.5 million and $18.6 million over a term of 10.5 years and 12 years, respectively.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

The components of lease expense during the three and six months ended March 31, 2025 and 2024 were as follows:


	Three Months Ended March 31,				Six Months Ended March 31,
Lease Expense	2025		2024		2025		2024
Operating lease expense(1)	$	7,663	$	7,597	$	15,265	$	15,259
Finance lease expense:
Amortization of leased assets	227		227		454		454
Interest on lease liabilities	65		79		135		161
Variable lease expense	2,537		2,476		5,153		4,837
Sublease income	(30)		(33)		(59)		(65)
Total net lease expense	$	10,462	$	10,346	$	20,948	$	20,646

(1) Excludes the expense for short-term leases, which was not significant for the three and six months ended March 31, 2025 and 2024.

Supplemental balance sheet, cash flow and other information related to our leases was as follows (in thousands, except lease term and discount rate):


Leases	Classification	March 31, 2025		September 30, 2024
Assets:
Operating lease assets	Right-of-use assets for operating leases	$	152,118	$	158,778
Finance lease assets	Property and equipment, net(1)	3,482		3,937
Total leased assets		$	155,600	$	162,715

Liabilities:
Current
Operating lease liabilities	Operating lease liabilities, current portion	$	21,927	$	22,210
Finance lease liabilities	Long-term debt, current portion(1)	980		934
Non-current
Operating lease liabilities	Operating lease liabilities	140,586		146,831
Finance lease liabilities	Long-term debt	3,335		3,834
Total lease liabilities		$	166,828	$	173,809

(1) The finance lease assets and liabilities as of March 31, 2025 and September 30, 2024 consisted of one facility lease. Finance lease assets are recorded net of accumulated amortization of $2.1 million and $1.7 million as of March 31, 2025 and September 30, 2024, respectively.


Lease Term and Discount Rate	March 31, 2025		September 30, 2024
Weighted-average remaining lease term (in years):
Operating leases	6.82		7.14
Finance lease	3.83		4.33

Weighted average discount rate:
Operating leases	4.90	%	4.87	%
Finance lease	6.02	%	6.02	%

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)


	Six Months Ended March 31,
Supplemental Disclosure of Cash Flow and Other Information	2025		2024
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	11,185	$	10,139
Financing cash flows from finance leases	453		410

Non-cash activity related to lease liabilities:
Lease assets obtained in exchange for new operating lease liabilities(1)	$	4,656	$	3,921

(1) During the six months ended, March 31, 2025, we recorded the facility lease for the new Concorde co-branded Heartland Dental campus expected to open in Fort Meyers, Florida during fiscal 2026 as we took possession to begin our construction.

Maturities of lease liabilities were as follows:


	As of March 31, 2025
Years ending September 30,	Operating Leases		Finance Lease
Remainder of 2025	$	14,682	$	602
2026	29,907		1,226
2027	29,394		1,263
2028	27,545		1,301
2029	26,830		439
2030 and thereafter	62,961		—
Total lease payments	191,319		4,831
Less: interest	(28,806)		(516)
Present value of lease liabilities	162,513		4,315
Less: current lease liabilities	(21,927)		(980)
Long-term lease liabilities	$	140,586	$	3,335

Note 9 - Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following:


	March 31, 2025		September 30, 2024
Accounts payable	$	19,823	$	26,273
Accrued compensation and benefits	34,129		35,660
Accrued tool sets	5,473		4,807
Other accrued expenses	20,332		17,126
Total accounts payable and accrued expenses	$	79,757	$	83,866

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 10 - Debt


	March 31, 2025					September 30, 2024
	Interest Rate		Maturity Date	Carrying Value of Debt(6)		Carrying Value of Debt(6)
Revolving Credit Facility(1)	6.17	%	Nov 2027	$	26,000	$	56,000
Avondale Term Loan(2)	6.37	%	May 2028	27,949		28,390
Lisle Term Loan(3)	6.32	%	Apr 2029	36,494		36,929
Finance lease(4)	6.02	%	Jan 2029	4,315		4,768
Total debt				94,758		126,087
Debt issuance costs presented with debt (5)				(337)		(383)
Total debt, net				94,421		125,704
Less: current portion of long-term debt				(2,779)		(2,697)
Long-term debt				$	91,642	$	123,007

(1) Interest on the Revolving Credit Facility (as defined below) accrues at an annual rate equal to Term SOFR plus a margin of 1.85%.

(2) Interest on the Avondale Term Loan (as defined below) accrues at a rate equal to one-month Term SOFR plus 2.0% and a tranche adjustment of 0.046%.

(3) Interest on the Lisle Term Loan (as defined below) accrues at a rate equal to one-month Term SOFR plus 2.0%.

(4) The finance lease is related to a facility lease with an annual interest rate of 6.02% that matures in 2029. See Note 8 for additional details on our finance lease.

(5) The unamortized debt issuance costs relate to the Avondale Term Loan and the Lisle Term Loan.

(6) The Revolving Credit Facility, Avondale Term Loan, Lisle Term Loan and finance leases bear interest at rates commensurate with market rates, and therefore, the respective carrying values approximate fair value (Level 2).

Revolving Credit Facility

On November 18, 2022, we entered into a $100.0 million senior secured revolving credit facility with Fifth Third Bank (the “Credit Facility” or “Revolving Credit Facility”), which included a $20.0 million sub facility available for letters of credit. On September 26, 2024, we amended the Credit Facility to increase the commitment amount to $125.0 million, extend the maturity date to November 30, 2027, and provide for the option to request an increase of up to an additional $25.0 million, which may be granted at the lender’s discretion to grant such increase. Advances made under the Credit Facility bear interest at an annual rate equal to (i) the Term SOFR rate, (ii) the Daily Simple SOFR rate, or (iii) the Base Rate (i.e., the greater of 3.5% and the lender’s prime rate). In each case that a SOFR rate is selected, an applicable margin that varies from 1.85% up to 2.35%, based on our then-current total leverage ratio, is applied.

During the six months ended March 31, 2025, we made payments on the Credit Facility of $30.0 million. The remaining availability under the Credit Facility as of March 31, 2025 was $99.0 million.

Avondale Term Loan

In connection with the Avondale, Arizona building purchase in December 2020, we entered into a credit agreement with Fifth Third Bank (the “Avondale Lender”) on May 12, 2021 in the maximum principal amount of $31.2 million with a maturity of seven years (the “Avondale Term Loan”). The Avondale Term Loan bears interest at the rate of Term SOFR plus 2.0% and a tranche rate adjustment of 0.046%. Principal and interest payments are due monthly. The Avondale Term Loan is secured by

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

a first priority lien on our Avondale, Arizona property, including all land and improvements. Additionally, we entered into an interest rate swap agreement with the Avondale Lender. See Note 11 for further discussion on the interest rate swap.

Lisle Term Loan

On April 14, 2022, our consolidated subsidiary, 2611 Corporate West Drive Venture LLC (the “Borrower”), entered into a new Loan Agreement (“Lisle Loan Agreement”) with Valley National Bank (the “Lisle Lender”), to fund the acquisition and retire the prior loan agreement with Western Alliance bank, via a term loan in the original principal amount of $38.0 million with a maturity of seven years (the “Lisle Term Loan” and together with the Avondale Term Loan, the “Term Loans”). The Lisle Term Loan bears interest at a rate of one-month Term SOFR plus 2.0%. The Lisle Term Loan is secured by a mortgage on the Lisle, Illinois campus and is guaranteed by the Company. In connection with the Lisle Term Loan, we entered into an interest rate swap agreement. See Note 11 for further discussion on the interest rate swap.

Debt Covenants for our Credit Facility and Term Loans

We are subject to certain customary affirmative and negative covenants under the Revolving Credit Facility and the Term Loans, including, without limitation, certain reporting obligations, certain limitations on restricted payments, limitations on liens, encumbrances and indebtedness and debt service coverage ratios. As of March 31, 2025, we were in compliance with all debt covenants.

Debt Maturities

Scheduled principal payments due on our debt for the remainder of 2025 and for each fiscal year through the period ended September 30, 2029, and thereafter were as follows at March 31, 2025:


Maturity	Revolving Credit Facility & Term Loans		Finance Lease		Total
Remainder of 2025	$	887	$	481	$	1,368
2026	1,837		1,029		2,866
2027	27,909		1,131		29,040
2028	26,610		1,239		27,849
2029	33,200		435		33,635
Thereafter	—		—		—
Subtotal	90,443		4,315		94,758
Debt issuance costs presented with debt	(337)		—		(337)
Total	$	90,106	$	4,315	$	94,421

Note 11 - Derivative Financial Instruments

In the normal course of business, our operations are exposed to market risks, including the effect of changes in interest rates. We may enter into derivative financial instruments to offset these underlying market risks.

On March 31, 2023, we entered into a new interest rate swap agreement, effective April 3, 2023, with the Avondale Lender that effectively fixes the interest rate we pay on 50% of the principal amount of the Avondale Term Loan at 1.45% for the entire loan term (the “Avondale Swap”). The Avondale Swap was designated as an effective cash flow hedge for accounting and tax purposes.

On April 14, 2022, in connection with the Lisle Term Loan, we entered into an interest rate swap agreement with the Lisle Lender that effectively fixes the interest rate on 50% of the principal amount of the Lisle Term Loan at 4.69% for the entire loan term, or seven years (the “Lisle Swap”). The Lisle Swap was designated as an effective cash flow hedge for accounting and tax purposes.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Changes in the fair value of derivatives that are designated and qualify as cash flow hedges are recorded in “Accumulated other comprehensive income” on the condensed consolidated balance sheets. For cash flow hedges, we report the effective portion of the gain or loss as a component of “Accumulated other comprehensive income” and reclassify it to “Interest expense” in the condensed consolidated statements of operations over the corresponding period of the underlying hedged item. The ineffective portion of the change in fair value of a derivative financial instrument is recognized in “Interest expense” at the time the ineffectiveness occurs. To the extent the hedged forecasted interest payments on debt related to our interest rate swap is paid off, the remaining balance in “Accumulated other comprehensive income” is recognized in “Interest expense” in the condensed consolidated statements of operations. Of the net amount of the existing gains that are reported in “Accumulated other comprehensive income” as of March 31, 2025, we estimate that $0.6 million will be reclassified to “Interest expense” within the next twelve months. As of March 31, 2025, the notional amount of the Avondale Swap and Lisle Swap was approximately $14.0 million and $18.2 million, respectively.

Fair Value of Derivative Instruments

The following table presents the fair value of our Avondale Swap and Lisle Swap (Level 2) which are designated as cash flow hedges and the related classification on the condensed consolidated balance sheets as of March 31, 2025 and September 30, 2024:


Interest Rate Swaps	March 31, 2025		September 30, 2024
Other current assets	$	517	$	497
Other assets	917		726
Total fair value of assets designated as hedging instruments	$	1,434	$	1,223

Effect of Cash Flow Hedge Accounting on the Consolidated Statements of Operations and Accumulated Other Comprehensive Income

The table below presents the effect of cash flow hedge accounting for our Avondale Swap and Lisle Swap on the condensed consolidated statement of operations and “Accumulated other comprehensive income” for the three and six months ended March 31, 2025 and 2024:


	Amount of Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivative, net of taxes	Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income
	Three Months Ended March 31, 2025
Avondale Swap and Lisle Swap	$(211)	$176

	Six Months Ended March 31, 2025
Avondale Swap and Lisle Swap	$545	$387

	Three Months Ended March 31, 2024
Avondale Swap and Lisle Swap	$(738)	$(267)

	Six Months Ended March 31, 2024
Avondale Swap and Lisle Swap	$174	$(538)

Note 12 - Income Taxes

Our income tax expense for the three months ended March 31, 2025 was $5.4 million, or 32.0% of pre-tax income, compared to $2.8 million, or 26.2% of pre-tax income, for the three months ended March 31, 2024. For the six months ended March 31, 2025, our income tax expense was $10.8 million, or 24.3% of pre-tax income, compared to $5.9 million, or 24.6% of pre-tax income, for the six months ended March 31, 2024. The effective income tax rate for the three and six months ended March

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

31, 2025 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, stock-based compensation expense, refinements to the federal research and development tax credits and state and local income and franchise taxes. The effective income tax rate for the three and six months ended March 31, 2024 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, stock-based compensation expense, refinements to the federal research and development tax credits and state and local income and franchise taxes.

As of each reporting date, management considers new evidence, both positive and negative, that could affect its view of the future realization of deferred tax assets. As of March 31, 2025, we continued to maintain a valuation allowance related to certain federal and state attributes, which are not expected to be utilized prior to expiration.

Note 13 - Restructuring Costs

On December 5, 2023, UTI announced plans to consolidate the two Houston, Texas campus locations to align the curriculum, student facing systems, and support services to better serve students seeking careers in in-demand fields. Both facilities will remain in use post-consolidation. As part of the transition, the MIAT Houston campus, acquired in November 2021, began a phased teach-out in May 2024 and began operating under the UTI brand. The consolidation into a single UTI Houston campus was completed during the three months ended December 31, 2024, reducing the number of UTI campuses from 16 to 15.

The total costs of the restructuring plan are estimated to be approximately $1.2 million and relate to the UTI segment. From announcement through March 31, 2025, we have incurred total restructuring costs of $0.2 million.

There were no restructuring costs expensed during the three months ended March 31, 2025. During the six months ended March 31, 2025, we expensed $43 thousand of restructuring costs primarily related to student financing costs, employee termination costs and tools, with $12 thousand reported in “Educational services and facilities” and the remainder reported in “Selling, general and administrative” on the condensed consolidated statements of operations.

During the three months ended March 31, 2024 and the six months ended March 31, 2024, we expensed $45 thousand of tool related costs and $88 thousand of employee termination and tool related costs, respectively, all of which are reported in “Selling, general and administrative” on the condensed consolidated statements of operations.

As of March 31, 2025, the only remaining cost related to this restructuring is the potential for federal loan discharges which we are estimating could be up to $1.0 million.

Note 14 - Commitments and Contingencies

Legal

Where a loss is not probable but is reasonably possible, including if a loss in excess of an accrued liability is reasonably possible, we determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claims. We are not currently a party to any material legal proceedings, but note that legal proceedings could, generally, have a material adverse effect on our business, cash flows, results of operations or financial condition.

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 15 - Shareholders' Equity

Common Stock

Holders of our common stock are entitled to receive dividends when and as declared by our Board of Directors and have the right to one vote per share on all matters requiring shareholder approval. On June 9, 2016, our Board of Directors voted to eliminate the quarterly cash dividend on our common stock.

Preferred Stock

As of March 31, 2025 and September 30, 2024, no shares of the Series A Convertible Preferred Stock with a $0.0001 par value each (“Series A Preferred Stock”) remain outstanding.

On December 18, 2023, we entered into a preferred stock repurchase agreement, pursuant to which we repurchased 33,300 shares of Series A Preferred Stock for an aggregate purchase price of $11.3 million. Following the repurchase of those shares, all remaining outstanding shares of Series A Preferred Stock were converted into Common Stock and we made a final dividend payment of $1.1 million to the Series A Preferred Stock holders of record as of December 18, 2023. As a result of the conversion, the aggregate 642,585 remaining shares of Series A Preferred Stock outstanding were converted into 19,296,843 shares of Common Stock. No shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated as of the December 18, 2023 conversion date. For further discussion, see Note 18 on “Shareholders’ Equity” included in our 2024 Annual Report on Form 10-K.

Share Repurchase Program

On December 10, 2020, our Board of Directors authorized a share repurchase plan that would allow for the repurchase of up to $35.0 million of our common stock in the open market or through privately negotiated transactions. This share repurchase plan replaced the previously authorized plan from fiscal 2012. We have not repurchased any shares under the $35.0 million share repurchase program, including during the six months ended March 31, 2025 or 2024.

Note 16 - Earnings per Share

Prior to the preferred stock conversion, we calculated basic and diluted earnings per common share (“EPS”) pursuant to the two-class method. The two-class method is an earnings allocation formula that determines EPS for common stock and participating securities according to dividend and participation rights in undistributed earnings. Under this method, all earnings, distributed and undistributed, are allocated to common shares and participating securities based on their respective rights to receive dividends. Dilutive potential common shares include outstanding stock options, unvested restricted share units and convertible preferred stock. As noted above in Note 15, no shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated as of the December 18, 2023 conversion date.

The following table summarizes the computation of basic and diluted EPS and the anti-dilutive shares excluded:


	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2025		2024		2025		2024
Basic earnings per common share:
Net income	$	11,446	$	7,787	$	33,599	$	18,176
Less: Preferred stock dividend declared	—		—		—		(1,097)
Net income available for distribution	11,446		7,787		33,599		17,079
Income allocated to participating securities	—		—		—		(2,855)
Net income available to common shareholders	$	11,446	$	7,787	$	33,599	$	14,224

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)


	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2025		2024		2025		2024
Weighted average basic shares outstanding	54,383		53,757		54,183		45,048

Basic income per share	$	0.21	$	0.14	$	0.62	$	0.32

Diluted earnings per common share:
Net income available to common shareholders	$	11,446	$	7,787	$	33,599	$	14,224

Weighted average basic shares outstanding	54,383		53,757		54,183		45,048
Dilutive effect related to employee stock plans	1,059		1,013		1,232		1,002
Weighted average diluted shares outstanding	55,442		54,770		55,415		46,050

Diluted income per common share	$	0.21	$	0.14	$	0.61	$	0.31

Anti-dilutive shares excluded:
Outstanding stock-based grants	1		—		285		17

Total anti-dilutive shares excluded	1		—		285		17

Note 17 - Segment Information

We operate our business in two reportable segments: (i) the UTI segment; and (ii) the Concorde segment. These segments are organized by key market segments to enhance operational alignment within each segment to more effectively execute our strategic plan. Each reportable segment represents a group of post-secondary education providers that offer a variety of degree and non-degree academic programs. “Corporate” includes corporate related expenses that are not allocated to the UTI or Concorde reportable segments and is included to reconcile segment results to the condensed consolidated financial statements.

Summary information by reportable segment is as follows:


	UTI		Concorde		Corporate		Consolidated
Three Months Ended March 31, 2025
Revenues	$	134,228	$	73,219	$	—	$	207,447
Income (loss) from operations	21,439		8,882		(13,468)		16,853
Depreciation and amortization	5,971		1,850		317		8,138
Net income (loss)	20,179		8,837		(17,570)		11,446

Three Months Ended March 31, 2024
Revenues	$	123,323	$	60,853	$	—	$	184,176
Income (loss) from operations	18,086		3,246		(10,140)		11,192
Depreciation and amortization	5,684		1,217		301		7,202
Net income (loss)	16,616		3,320		(12,149)		7,787

Table of Contents

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)


	UTI		Concorde		Corporate		Consolidated
Six Months Ended March 31, 2025
Revenues	$	265,706	$	143,170	$	—	$	408,876
Income (loss) from operations	46,892		20,077		(22,638)		44,331
Depreciation and amortization	11,942		3,559		636		16,137
Net income (loss)	44,507		20,002		(30,910)		33,599

Six Months Ended March 31, 2024
Revenues	$	238,697	$	120,174	$	—	$	358,871
Income (loss) from operations	33,177		10,373		(18,127)		25,423
Depreciation and amortization	11,178		2,371		637		14,186
Net income (loss)	30,213		10,493		(22,530)		18,176

As of March 31, 2025
Total assets	$	441,775	$	123,733	$	154,935	$	720,443

As of September 30, 2024
Total assets	$	440,764	$	125,212	$	178,599	$	744,575

Note 18 - Government Regulation and Financial Aid

As discussed at length in our 2024 Annual Report on Form 10-K, our institutions participate in a range of government-sponsored student assistance programs. The most significant of these is the federal student aid programs administered by the U.S. Department of Education (“ED”) pursuant to Title IV of the HEA, commonly referred to as the Title IV Programs. Generally, to participate in the Title IV Programs, an institution must be licensed or otherwise legally authorized to operate in the state where it is physically located, be accredited by an accreditor recognized by ED, be certified as an eligible institution by ED, offer at least one eligible program of education, and comply with other statutory and regulatory requirements.

Each of our institutions holds the state or other authorizations required to operate and offer postsecondary education programs, and to recruit in the states in which it engages in recruiting activities. In addition, our institutions are accredited by ED-recognized accreditors: all of the UTI institutions and 14 of the Concorde institutions are accredited by the Accrediting Commission of Career Schools and Colleges, while the remaining three Concorde institutions are accredited by the Council on Occupational Education. ED will certify an institution to participate in the Title IV programs only after the institution has demonstrated compliance with the HEA and ED’s extensive regulations regarding institutional eligibility. An institution must also demonstrate its compliance to ED on an ongoing basis. As of March 31, 2025, management believes the Company and its institutions are in compliance with the applicable regulations in all material respects. See “Part I, Item 1. Regulatory Environment” and “Part I, Item 1. State and Accreditor Approvals” in our 2024 Annual Report on Form 10-K for a detailed discussion of the regulatory environment in which the Company operates.

Because the Company operates in a highly regulated industry, it, like other industry participants, may be subject from time to time to investigations, claims of non-compliance, or lawsuits by governmental agencies or third parties, which allege statutory violations, regulatory infractions, or common law causes of action. There can be no assurance that regulatory agencies or third parties will not undertake investigations or make claims against the Company, or that such claims, if made, will not have a material adverse effect on the Company’s business, results of operations or financial condition.

Table of Contents

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with the condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and those in our 2024 Annual Report on Form 10-K. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those anticipated in such forward-looking statements as a result of certain factors, including but not limited to those described under “Risk Factors” in our 2024 Annual Report on Form 10-K and included in Part II, Item 1A of this Quarterly Report on Form 10-Q. See also “Cautionary Note Regarding Forward-Looking Statements” on page ii of this Quarterly Report on Form 10-Q.

Company Overview

Universal Technical Institute (“UTI”): UTI operates 15 campuses located in nine states and offers a wide range of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute, Marine Mechanics Institute, NASCAR Technical Institute, and MIAT College of Technology (“MIAT”). UTI also offers manufacturer specific advanced training programs, which include student-paid electives, at our campuses and manufacturer or dealer sponsored training at certain campuses and dedicated training centers. Lastly, UTI provides dealer technician training or instructor staffing services to manufacturers. UTI works closely with multiple original equipment manufacturers and industry brand partners to understand their needs for qualified service professionals.

Concorde Career Colleges (“Concorde”): Concorde operates across 17 campuses in eight states and online, offering degree, non-degree, certificate and continuing education programs in the allied health, dental, nursing, patient care and diagnostic fields. The Company has designated campuses that offer degree granting programs as “Concorde Career College” where allowed by state regulation. The remaining campuses are designated as “Concorde Career Institute.” Concorde believes in preparing students for their health care careers with practical, hands-on experiences including opportunities to learn while providing care to real patients. Prior to graduation, students will complete a number of hours in a clinical setting or externship, depending upon their program of study.

“Corporate” includes corporate related expenses that are not allocated to the UTI or Concorde reportable segments. See Note 17 of the notes to the condensed consolidated financial statements herein for additional details on our segments.

All of our campuses are accredited and are eligible for federal student financial assistance funds under the Higher Education Act of 1965, as amended, commonly referred to as Title IV Programs, which are administered by the U.S. Department of Education (“ED”). Our programs are also eligible for financial aid from federal sources other than Title IV Programs, such as the programs administered by the U.S. Department of Veterans Affairs and under the Workforce Innovation and Opportunity Act.

We believe that our industry-focused educational model and national presence has enabled us to develop valuable industry relationships, which provide us with significant competitive advantages and supports our market leadership, along with enabling us to provide highly specialized education to our students, resulting in enhanced employment opportunities and the potential for higher wages for our graduates.

Table of Contents

Overview of the Three and Six Months Ended March 31, 2025

Student Metrics


	Three Months Ended				Six Months Ended
	March 31,		%		March 31,		%
	2025	2024	Change		2025	2024	Change
UTI
Total new student starts	3,591	2,840	26.4	%	6,344	5,154	23.1	%
Average full-time active students	14,777	13,810	7.0	%	15,121	14,065	7.5	%
End of period full-time active students	14,959	13,590	10.1	%	14,959	13,590	10.1	%
Concorde
Total new student starts	3,059	2,640	15.9	%	5,619	4,672	20.3	%
Average full-time active students	9,827	8,506	15.5	%	9,713	8,375	16.0	%
End of period full-time active students	9,892	8,487	16.6	%	9,892	8,487	16.6	%
Consolidated
Total new student starts	6,650	5,480	21.4	%	11,963	9,826	21.7	%
Average full-time active students	24,604	22,316	10.3	%	24,834	22,440	10.7	%
End of period full-time active students	24,851	22,077	12.6	%	24,851	22,077	12.6	%

For the three and six months ended March 31, 2025, the increase in consolidated and segment new student starts, average full-time active students and end of period full-time active students was primarily due to new program rollouts and increased student demand for existing programs across both segments as compared to the prior year. In the UTI segment, increases to our student population during the three and six months ended March 31, 2025 were driven by the successful launch of three new HVAC and refrigeration programs launched in the second half of fiscal 2024 and two new HVACR programs in fiscal 2025. The Concorde segment benefited from the launch of five new programs at three campuses during fiscal 2024, and the introduction of new cash pay “short programs” at a number of campuses.

Our ability to start new students can be influenced by various factors including: the state of the general macro-economic environment and its impact on price sensitivity and the ability and willingness of students and their families to incur debt to fund their education; unemployment rates; competition; adverse media coverage, legislative, or regulatory actions and investigations by attorneys general and various agencies related to allegations of wrongdoing on the part of other companies within the education and training services industry, which can cast the aggregate “for-profit” education industry in a negative light; and pandemics and or other national, state or local emergencies as declared by various government authorities.

Operations

Revenues for the three months ended March 31, 2025 were $207.4 million, an increase of $23.3 million, or 12.6%, from the comparable period in the prior year. UTI revenues increased by approximately $10.9 million, or 8.8%, and Concorde revenues increased by approximately $12.4 million, or 20.3%. Both segment increases were primarily driven by the higher average full-time active students.

Revenues for the six months ended March 31, 2025 were $408.9 million, an increase of $50.0 million, or 13.9%, from the comparable period in the prior year. UTI revenues increased by approximately $27.0 million, or 11.3%, and Concorde revenues increased by approximately $23.0 million, or 19.1%. Both segment increases were primarily driven by the higher average full-time active students.

Total income from operations was $16.9 million and $44.3 million during the three and six months ended March 31, 2025, compared to $11.2 million and $25.4 million for the three and six months ended March 31, 2024. The increase for the three and six months ended March 31, 2025 was primarily driven by the increased revenues from the larger student population. Additionally, productivity improvements and proactive cost reductions have been a key part of our operating model for the past several years, and we continue to identify and execute on optimization opportunities throughout our operations in both segments.

Table of Contents

Business Strategy

Our business strategy, internally known as our “North Star strategy,” has three core tenets: (i) to grow the business by more deeply penetrating existing target markets and adding new markets; (ii) to diversify the business by adding new locations, programs, and offerings that maximize the lifetime value of our students; and (iii) to continually optimize the business by constantly enhancing operational efficiency.

During the six months ended March 31, 2025, we executed the following as part of our business strategy:

•UTI announced Atlanta, Georgia as the location of its next UTI division campus (“UTI Atlanta”), continuing the company's execution of its North Star strategy. Pending regulatory approvals, UTI Atlanta will open in 2026.

•UTI announced the division’s second new campus will be in San Antonio, Texas (“UTI San Antonio”). This new campus, once open, will be our first skilled trades and energy education focused campus. Similar to above, pending regulatory approvals, UTI San Antonio will open in 2026, bringing the total number of UTI campuses nationwide to 17.

•Concorde signed a new facility lease agreement related to our partnership with Heartland Dental to construct a new co-branded campus in Fort Myers, Florida, which is expected to open in early fiscal 2026. Construction began during the second quarter of 2025.

•UTI has announced the expansion of its successful Manufacturer Specific Advanced Training program by adding Tesla's START Collision Repair program. Tesla's START program is an intensive training program that prepares workers for successful careers at Tesla and will be will be available at the Long Beach, California campus beginning in the third quarter of 2025.

•UTI launched its HVACR program at the Sacramento, California and Orlando, Florida campuses in March 2025. The program covers topics such as air handling, AC and DC circuits, sheet metal ductwork, and troubleshooting.

•UTI announced the expansion of its core automotive program to include new Battery Hybrid Electric Vehicle and Electric Vehicle (“EV”) courses with roll out completed during the first quarter of 2025 at the Avondale, Arizona and Orlando, Florida campuses. Further rollout was completed during the second quarter of 2025 at the following campuses: Bloomfield, New Jersey; Dallas, Texas; Austin, Texas; and Houston, Texas. The program is expected to launch at the Miramar, Florida campus during the third quarter of 2025. This expansion builds on existing EV training at UTI's California campuses and covers topics such as high-voltage vehicle operation, electric vehicle components, diagnosis, and service.

In addition, we continue to pursue other opportunities that align with our business strategy.

Regulatory Environment

See Note 18 of the notes to our condensed consolidated financial statements herein for a discussion of our regulatory environment.

Table of Contents

Results of Operations: Three Months Ended March 31, 2025 Compared to Three Months Ended March 31, 2024

The following table sets forth selected statements of operations data as a percentage of revenues for each of the periods indicated.


	Three Months Ended March 31,
	2025		2024
Revenues	100.0	%	100.0	%
Operating expenses:
Educational services and facilities	49.4	%	52.9	%
Selling, general and administrative	42.5	%	41.0	%
Total operating expenses	91.9	%	93.9	%
Income from operations	8.1	%	6.1	%
Interest income	0.8	%	0.8	%
Interest expense	(0.8)	%	(1.2)	%
Other income (expense), net	—	%	0.1	%
Total other income (expense), net	—	%	(0.3)	%
Income before income taxes	8.1	%	5.7	%
Income tax expense	(2.6)	%	(1.5)	%
Net income	5.5	%	4.2	%
Preferred stock dividends	—	%	—	%
Income available for distribution	5.5	%	4.2	%
Income allocated to participating securities	—	%	—	%
Net income available to common shareholders	5.5	%	4.2	%

Revenues

The following table presents revenue by segment (in thousands):


	Three Months Ended March 31, 2025									Three Months Ended March 31, 2024
	UTI			Concorde			Consolidated			UTI		Concorde		Consolidated
Revenue	$	134,228		$	73,219		$	207,447		$	123,323	$	60,853	$	184,176
Year over Year % Change	8.8		%	20.3		%	12.6		%

Revenues for the three months ended March 31, 2025 were $207.4 million, an increase of $23.3 million, or 12.6%, as compared to revenues of $184.2 million for the three months ended March 31, 2024.

UTI

Revenues for UTI for the three months ended March 31, 2025 were $134.2 million compared to $123.3 million in the prior period. Revenue increased primarily due to a 26.4% increase in new student starts and an 7.0% increase in average full-time active students from the prior period.

Concorde

Revenues for Concorde for the three months ended March 31, 2025 were $73.2 million compared to $60.9 million in the prior period. Revenues increased primarily due to a 15.9% increase new student starts and a 15.5% increase in average full-time active students from the prior period.

Table of Contents

Educational services and facilities expenses

Educational services and facilities expenses were $102.5 million for the three months ended March 31, 2025, as compared to $97.5 million for the three months ended March 31, 2024. This increase was primarily due to the increased student volumes during the period and costs associated with execution of our business strategies, partially offset by cost savings from our operational initiatives.

The following tables set forth the significant components of our educational services and facilities expenses by segment (in thousands):


	Three Months Ended March 31, 2025
	UTI		Concorde		Consolidated
Salaries, employee benefits and tax expense	$	32,860	$	26,499	$	59,359
Bonus expense	723		547		1,270
Stock-based compensation	150		—		150
Compensation and related costs	33,733		27,046		60,779
Occupancy costs	7,781		5,427		13,208
Supplies, maintenance and student expense	6,470		3,948		10,418
Depreciation and amortization expense	5,939		1,597		7,536
Contract services expense	1,083		588		1,671
Other educational services and facilities expense	5,860		3,016		8,876
Total educational services and facilities expense	$	60,866	$	41,622	$	102,488


	Three Months Ended March 31, 2024
	UTI		Concorde		Consolidated
Salaries, employee benefits and tax expense	$	30,655	$	23,768	$	54,423
Bonus expense	746		333		1,079
Stock-based compensation	104		—		104
Compensation and related costs	31,505		24,101		55,606
Occupancy costs	7,586		5,424		13,010
Supplies, maintenance and student expense	8,102		4,351		12,453
Depreciation and amortization expense	5,585		754		6,339
Contract services expense	1,151		526		1,677
Other educational services and facilities expense	6,171		2,232		8,403
Total educational services and facilities expense	$	60,100	$	37,388	$	97,488

UTI

Compensation and related costs increased by $2.2 million for the three months ended March 31, 2025, primarily due to instructors and other personnel hired to support the newly launched programs and overall growth in the student population.

Supplies, maintenance and student expense decreased by $1.6 million for the three months ended March 31, 2025, primarily due to a decrease of $1.6 million in student housing expenses.

Table of Contents

Concorde

Compensation and related costs increased by $2.9 million for the three months ended March 31, 2025, primarily due to instructors and other personnel hired to support overall student growth and the launch of additional programs.

Depreciation and amortization expense increased by $0.8 million during the three months ended March 31, 2025, primarily due to capital expenditures related to new equipment, leasehold improvements, and program expansions to support a higher volume of students.

Other educational services and facilities expense increased by $0.8 million during the three months ended March 31, 2025, primarily due to higher expenses for training aids and insurance.

Selling, general and administrative expenses

Selling, general and administrative expenses for the three months ended March 31, 2025 were $88.1 million, as compared to $75.5 million for the three months ended March 31, 2024. This increase was primarily due to costs associated with our business strategies.

The following tables set forth the significant components of our selling, general and administrative expenses by segment (in thousands):


	Three Months Ended March 31, 2025
	UTI		Concorde		Corporate		Consolidated
Salaries, employee benefits and tax expense	$	20,448	$	6,798	$	5,945	$	33,191
Bonus expense	3,319		691		2,430		6,440
Stock-based compensation	417		189		2,268		2,874
Compensation and related costs	24,184		7,678		10,643		42,505
Advertising and marketing expense	15,849		7,895		211		23,955
Professional and contract services expense	2,036		738		4,126		6,900
Other selling, general and administrative expenses	9,854		6,404		(1,512)		14,746
Total selling, general and administrative expenses	$	51,923	$	22,715	$	13,468	$	88,106


	Three Months Ended March 31, 2024
	UTI		Concorde		Corporate		Consolidated
Salaries, employee benefits and tax expense	$	20,105	$	7,173	$	3,862	$	31,140
Bonus expense	2,677		496		1,128		4,301
Stock-based compensation	209		69		1,972		2,250
Compensation and related costs	22,991		7,738		6,962		37,691
Advertising and marketing expense	13,900		7,040		211		21,151
Professional and contract services expense	1,620		2,232		3,014		6,866
Other selling, general and administrative expenses	6,626		3,209		(47)		9,788
Total selling, general and administrative expenses	$	45,137	$	20,219	$	10,140	$	75,496

UTI

Compensation and related costs increased by $1.2 million for the three months ended March 31, 2025 primarily due to additional headcount hired to support the UTI segment and execution of our business strategies.

Advertising and marketing expense increased year over year by $1.9 million. UTI advertising and marketing expense as a percentage of revenues increased to 11.8% for the three months ended March 31, 2025 as compared to 11.3% in the prior year.

Table of Contents

Other selling, general and administrative expenses increased by $3.2 million primarily due to a $2.1 million increase in allocated corporate expenses related to human resources and information technology due to growth in headcount to support the UTI segment and our business strategies. Additionally, the provision for credit losses increased by $1.6 million over the prior year as a result of higher revenue and student volumes.

Concorde

Compensation and related costs decreased by $0.1 million for the three months ended March 31, 2025 primarily due to continued integration activities and the centralization of more processes within the Corporate division.

Advertising and marketing increased year over year by $0.9 million. Concorde advertising and marketing expense as a percentage of revenues for the three months ended March 31, 2025 and 2024 was 10.8% and 11.6%, respectively.

Professional and contract services expense decreased by $1.5 million for the three months ended March 31, 2025 primarily due to a reduction of legal and outside service expenses as several of the integration activities were completed in the prior year.

Other selling, general and administrative expenses increased by $3.2 million for the three months ended March 31, 2025 primarily related to an increase in the provision for credit losses of $2.7 million and an increase in software expenses of $0.4 million. These increases are aligned with higher revenue and higher capital expenditures to support larger student volumes.

Corporate

Compensation and related costs increased by $3.7 million three months ended March 31, 2025 primarily due to additional headcount hired to support the execution of our business strategies.

Professional fees and contract services increased by $1.1 million for the three months ended March 31, 2025 primarily due to consulting costs incurred for a potential acquisition of $0.9 million.

Other selling, general and administrative expenses decreased by $1.5 million for the three months ended March 31, 2025 primarily due to $2.4 million higher corporate expenses related to human resources and information technology allocated to the UTI and Concorde segments due to overall increase in expenses compared to the prior period. This decrease is partially offset by a $0.5 million increase in software expense and a $0.3 million increase in employment advertising.

Income taxes

Income tax expense for the three months ended March 31, 2025 was $5.4 million, or 32.0% of pre-tax income, compared to $2.8 million, or 26.2% of pre-tax income, for the three months ended March 31, 2024. The effective income tax rate for the three months ended March 31, 2025 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, stock-based compensation expense, refinements to the federal research and development tax credits and state and local income and franchise taxes. The effective income tax rate for the three months ended March 31, 2024 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, federal research and development tax credits and state and local income and franchise taxes. See Note 12 of the notes to the condensed consolidated financial statements herein for additional details.

Preferred stock dividends

As of March 31, 2025, no shares of Series A Convertible Preferred Stock, (the “Series A Preferred Stock”) remained outstanding and all rights of the holders to receive future dividends have been terminated due to the combination of the repurchase and conversion of all outstanding preferred shares as of December 18, 2023. See Note 18 included in our 2024 Annual Report on Form 10-K for additional details on the conversion of our Series A Preferred Stock.

There was no preferred stock cash dividend for the three months ended March 31, 2024.

Table of Contents

Income available for distribution

Income available for distribution refers to net income reduced by dividends on our Series A Preferred Stock. As a result of the foregoing, we reported income available for distribution of $11.4 million for the three months ended March 31, 2025 and income available for distribution of $7.8 million for three months ended March 31, 2024.

Income allocated to participating securities

Series A Preferred Stock was considered a participating security because, in the event that we paid a dividend or make a distribution on the outstanding common stock, we should also pay each holder of the Series A Preferred Stock a dividend on an as-converted basis. The two-class method is an earnings allocation formula that determines earnings per share for common stock and participating securities according to dividend and participation rights in undistributed earnings. Under this method, all earnings, distributed and undistributed, are allocated to common shares and participating securities based on their respective rights to receive dividends.

As noted above, no shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated as of the December 18, 2023 conversion date. As such, there was no income allocated to participating securities for the three months ended March 31, 2025 and 2024.

Net income available to common shareholders

We had net income of $11.4 million and $7.8 million available to common shareholders for the three months ended March 31, 2025 and 2024, respectively.

Results of Operations: Six Months Ended March 31, 2025 Compared to Six Months Ended March 31, 2024

The following table sets forth selected statements of operations data as a percentage of revenues for each of the periods indicated.


	Six Months Ended March 31,
	2025		2024
Revenues	100.0	%	100.0	%
Operating expenses:
Educational services and facilities	49.6	%	52.9	%
Selling, general and administrative	39.6	%	40.0	%
Total operating expenses	89.2	%	92.9	%
Income from operations	10.8	%	7.1	%
Interest income	0.8	%	0.9	%
Interest expense	(0.8)	%	(1.4)	%
Other income (expense), net	—	%	0.1	%
Total other (expense), net	—	%	(0.4)	%
Income before income taxes	10.8	%	6.7	%
Income tax expense	(2.6)	%	(1.7)	%
Net income	8.2	%	5.1	%
Preferred stock dividends	—	%	(0.3)	%
Income available for distribution	8.2	%	4.8	%
Income allocated to participating securities	—	%	(0.8)	%
Net income available to common shareholders	8.2	%	4.0	%

Table of Contents

Revenues

The following table presents revenue by segment (in thousands):


	Six Months Ended March 31, 2025									Six Months Ended March 31, 2024
	UTI			Concorde			Consolidated			UTI		Concorde		Consolidated
Revenue	$	265,706		$	143,170		$	408,876		$	238,697	$	120,174	$	358,871
Year over Year % Change	11.3		%	19.1		%	13.9		%

Revenues for the six months ended March 31, 2025 were $408.9 million, an increase of $50.0 million, or 13.9%, as compared to revenues of $358.9 million for the six months ended March 31, 2024.

UTI

Revenues for UTI for the six months ended March 31, 2025 were $265.7 million compared to $238.7 million in the prior year period. Revenue increased primarily due to a 23.1% increase in new student starts and a 7.5% increase in average full-time active students from the prior period. This increase in revenue is also related to an overall increase in average revenue per student.

Concorde

Revenues for Concorde for the six months ended March 31, 2025 were $143.2 million compared to $120.2 million in the prior year period. Revenues increased primarily due to an 20.3% increase in new student starts and a 16.0% increase in average full-time active students from the prior period.

Educational services and facilities expenses

Educational services and facilities expenses were $202.6 million for the six months ended March 31, 2025, as compared to $189.9 million for the six months ended March 31, 2024, which was primarily due to the increased student volumes during the period and costs associated with execution of our business strategies, partially offset by cost savings from our operational initiatives.

The following table sets forth the significant components of our educational services and facilities expenses by segment (in thousands):


	Six Months Ended March 31, 2025
	UTI		Concorde		Consolidated
Salaries, employee benefit and tax expenses	$	63,698	$	52,387	$	116,085
Bonus expense	1,477		1,043		2,520
Stock-based compensation	204		—		204
Compensation and related costs	65,379		53,430		118,809
Occupancy costs	15,392		10,833		26,225
Supplies and maintenance and student expense	14,163		8,041		22,204
Depreciation and amortization expense	11,878		3,050		14,928
Contract services expense	2,034		1,181		3,215
Other educational services and facilities expense	11,742		5,506		17,248
Total educational services and facilities expense	$	120,588	$	82,041	$	202,629

Table of Contents


	Six Months Ended March 31, 2024
	UTI		Concorde		Consolidated
Salaries, employee benefit and tax expenses	$	57,558	$	45,594	$	103,152
Bonus expense	1,399		470		1,869
Stock-based compensation	191		—		191
Compensation and related costs	59,148		46,064		105,212
Occupancy costs	15,044		10,987		26,031
Supplies, maintenance and student expense	18,515		8,212		26,727
Depreciation and amortization expense	10,977		2,012		12,989
Contract services expense	2,035		1,029		3,064
Other educational services and facilities expense	11,749		4,125		15,874
Total educational services and facilities expense	$	117,468	$	72,429	$	189,897

UTI

Compensation and related costs increased by $6.2 million for the six months ended March 31, 2025 primarily due to instructors and other personnel hired to support the new programs added and overall growth in the student population.

Supplies, maintenance and student expense decreased by $4.4 million for the six months ended March 31, 2025 primarily due to a decrease in student housing expenses.

Depreciation and amortization expense increased by $0.9 million for the six months ended March 31, 2025 primarily due to increased capital expenditures related to the new program launches and expansions.

Concorde

Compensation and related costs increased by $7.4 million for the six months ended March 31, 2025 primarily due to increased instructors and other personnel hired to support overall growth in the student population and new program expansions.

Depreciation and amortization expense increased by $1.0 million during the six months ended March 31, 2025, primarily due to capital expenditures related to new equipment and leasehold improvements to support a higher volume of students.

Other educational services and facilities expense increased by $1.4 million during the six months ended March 31, 2025, primarily due to higher expense for training aids and insurance.

Selling, general and administrative expenses

Selling, general and administrative expenses for the six months ended March 31, 2025 were $161.9 million. This represents an increase of $18.4 million, as compared to $143.6 million for the six months ended March 31, 2024, which is primarily due to costs associated with our business strategies.

Table of Contents

The following table sets forth the significant components of our selling, general and administrative expenses by segment (in thousands):


	Six Months Ended March 31, 2025
	UTI		Concorde		Corporate		Consolidated
Salaries, employee benefit and tax expense	$	40,726	$	12,884	$	11,041	$	64,651
Bonus expense	6,132		1,153		3,767		11,052
Stock-based compensation	745		268		2,527		3,540
Compensation and related costs	47,603		14,305		17,335		79,243
Advertising and marketing expense	29,526		15,257		400		45,183
Professional and Contract services expense	3,783		1,484		7,853		13,120
Other selling, general and administrative expenses	17,314		10,006		(2,950)		24,370
Total selling, general and administrative expenses	$	98,226	$	41,052	$	22,638	$	161,916


	Six Months Ended March 31, 2024
	UTI		Concorde		Corporate		Consolidated
Salaries, employee benefit and tax expense	$	38,571	$	13,539	$	7,425	$	59,535
Bonus expense	5,518		1,216		2,150		8,884
Stock-based compensation	592		77		2,975		3,644
Compensation and related costs	44,681		14,832		12,550		72,063
Advertising and marketing expense	27,253		13,132		211		40,596
Professional and Contract services expense	3,323		3,599		5,521		12,443
Other selling, general and administrative expenses	12,796		5,808		(155)		18,449
Total selling, general and administrative expenses	$	88,053	$	37,371	$	18,127	$	143,551

UTI

Compensation and related costs increased by $2.9 million for the six months ended March 31, 2025 primarily due to an increase in headcount to support the UTI segment and execution of our business strategies.

Advertising and marketing expense increased by $2.3 million for the six months ended March 31, 2025. Advertising and marketing expense as a percentage of revenues decreased to 11.1% for the six months ended March 31, 2025 as compared to 11.4% in the prior year.

Other selling, general and administrative expenses increased by $4.5 million for the six months ended March 31, 2025 primarily due to a $3.2 million increase in allocated corporate expenses related to human resources and information technology due to growth in headcount to support the UTI segment and our business strategies. Additionally, the provision for credit losses increased by $2.1 million over the prior year as a result of higher revenue and student volumes.

Concorde

Concorde compensation and related costs decreased by $0.5 million for the six months ended March 31, 2025 primarily due to continued integration activities and the centralization of more processes within the Corporate division.

Advertising and marketing expense increased by $2.1 million for the six months ended March 31, 2025. Advertising and marketing expense as a percentage of revenues decreased to 10.7% for the six months ended March 31, 2025 as compared to 10.9% in the prior year period.

Other selling, general and administrative expense increased by $4.2 million for the six months ended March 31, 2025 primarily related to an increase in the provision for credit losses of $2.8 million, an increase in software expenses of $0.8 million, and an increase in allocated corporate expenses related to human resources of $0.4 million. These increases are aligned with higher revenue and higher capital expenditures to support larger student volumes.

Table of Contents

Corporate

Corporate compensation and related costs for increased by $4.8 million for the six months ended March 31, 2025 primarily due to additional headcount hired to support the execution of our business strategies.

Professional and contract services expense increased by $2.3 million for the six months ended March 31, 2025 due to an increase in consulting expenses of $1.0 million and an increase in legal expenses of $1.3 million.

Other selling, general and administrative expenses decreased by $2.8 million for the six months ended March 31, 2025 primarily due to $3.6 million higher corporate expenses related to human resources and information technology allocated to the UTI and Concorde segments due to an overall increase in expenses compared to the prior period. This decrease is partially offset by a $0.7 million increase in software expense.

Income taxes

Our income tax expense for the six months ended March 31, 2025 was $10.8 million, or 24.3% of pre-tax income, compared to $5.9 million, or 24.6% of pre-tax income, for the six months ended March 31, 2024. The effective income tax rate for the six months ended March 31, 2025 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, stock-based compensation expense, refinements to the federal research and development tax credits and state and local income and franchise taxes. The effective income tax rate for the six months ended March 31, 2024 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, federal research and development tax credits and state and local income and franchise taxes. See Note 12 of the notes to the condensed consolidated financial statements herein for additional details.

Preferred stock dividends

As of March 31, 2025, no shares of the Series A Preferred Stock remained outstanding and all rights of the holders to receive future dividends have been terminated due to the combination of the repurchase and conversion of all outstanding preferred shares as of December 18, 2023. See Note 15 of the notes to the condensed consolidated financial statements herein for additional details on the conversion of our Series A Preferred Stock.

Pursuant to the Certificate of Designations, we recorded a preferred stock cash dividend of $1.1 million for the six months ended March 31, 2024.

Income available for distribution

Income available for distribution refers to net income reduced by dividends on our Series A Preferred Stock. As a result of the foregoing, we reported income available for distribution of $33.6 million and $17.1 million for the six months ended March 31, 2025 and 2024, respectively.

Income allocated to participating securities

Our previously outstanding Series A Preferred Stock was considered a participating security because, in the event that we paid a dividend or made a distribution on the outstanding common stock, we were required to pay each holder of the Series A Preferred Stock a dividend on an as-converted basis. The two-class method is an earnings allocation formula that determines earnings per share for common stock and participating securities according to dividend and participation rights in undistributed earnings. Under this method, all earnings, distributed and undistributed, are allocated to common shares and participating securities based on their respective rights to receive dividends.

As noted above, no shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated as of the December 18, 2023 conversion date. There was no income allocated to participating securities for the six months ended March 31, 2025. The amount of income allocated to the participating securities for the six months ended March 31, 2024 was $2.9 million.

Net income available to common shareholders

After allocating the income to the participating securities, we had $33.6 million and $14.2 million of net income available to common shareholders for the six months ended March 31, 2025 and 2024, respectively.

Table of Contents

Non-GAAP Financial Measures

Our earnings before interest, income taxes, depreciation and amortization (“EBITDA”) for the three and six months ended March 31, 2025 were $25.0 million and $60.4 million, respectively, compared to $18.5 million and $39.9 million for the three and six months ended March 31, 2024. We define EBITDA as net income (loss), before interest (income) expense, income tax expense (benefit), and depreciation and amortization.

EBITDA is a non-GAAP financial measure which is provided to supplement, but not substitute for, the most directly comparable GAAP measure. We choose to disclose this non-GAAP financial measure because it provides an additional analytical tool to clarify our results from operations and helps to identify underlying trends. Additionally, this measure helps compare our performance on a consistent basis across time periods. Management also utilizes EBITDA as a performance measure internally. To obtain a complete understanding of our performance, this measure should be examined in connection with net income determined in accordance with GAAP. Since the items excluded from this measure should be examined in connection with net income in determining financial performance under GAAP, this measure should not be considered an alternative to net income as a measure of our operating performance or profitability. Exclusion of items in our non-GAAP presentation should not be construed as an inference that these items are unusual, infrequent or non-recurring. Other companies, including other companies in the education industry, may calculate EBITDA differently than we do, limiting its usefulness as a comparative measure across companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

EBITDA reconciles to net income, as follows (in thousands):


	Three Months Ended March 31,				Six Months Ended March 31,
	2025		2024		2025		2024
Net income	$	11,446	$	7,787	$	33,599	$	18,176
Interest income	(1,629)		(1,427)		(3,388)		(3,402)
Interest expense	1,657		2,184		3,330		5,055
Income tax expense	5,388		2,767		10,764		5,927
Depreciation and amortization	8,138		7,202		16,137		14,186
EBITDA	$	25,000	$	18,513	$	60,442	$	39,942

Liquidity and Capital Resources

Overview of Liquidity

Based on past performance and current expectations, we believe that our cash flows from operations, cash on hand and investments, and the Revolving Credit Facility will satisfy our working capital needs, capital expenditures, commitments and other liquidity requirements associated with our existing operations, as well as announced growth, diversification and optimization initiatives throughout the fiscal year and beyond. Our cash position is available to fund strategic long-term growth initiatives, including opening additional campuses in new markets and the creation and expansion of new programs in existing markets where we continue to optimize utilization of our campus facilities.

Our aggregate cash and cash equivalents were $96.0 million as of March 31, 2025, a decrease of $65.9 million from September 30, 2024 due primarily to cash used for purchases of held-to-maturity investments of $39.7 million and repayments of $31.3 million to the Revolving Credit Facility, term loans and finance leases. Our available liquidity under the Revolving Credit Facility was $99.0 million as of March 31, 2025.

Strategic Uses of Cash

We believe that uses of our cash resources may include consideration of additional strategic acquisitions and organic growth initiatives, the purchase of real estate assets, subsidizing funding alternatives for our students, and the repurchase of common stock, among others. To the extent that potential acquisitions are large enough to require financing beyond cash from operations, and cash and cash equivalents, or we need capital to fund operations, new campus openings or expansion of programs at existing campuses, we may enter into additional credit facilities, issue debt or issue additional equity.

Long-term Debt

As of March 31, 2025, we had $94.8 million of long-term debt outstanding, which is comprised of two term loans, a finance

Table of Contents

lease and our Revolving Credit Facility. Of the $94.8 million outstanding, $27.9 million relates to a term loan that bears interest at the rate of Term SOFR plus 2.0% and a tranche rate adjustment of 0.046% over the seven-year term secured in connection with the Avondale, Arizona campus property purchased in December 2020. Approximately $36.5 million relates to a term loan that bears interest at the rate of Term SOFR plus 2.0% over the seven-year term, secured in connection with the Lisle, Illinois campus property. For each of the term loans, a derivative interest rate swap is in place that fixes the interest rate on 50% of the loan at a market rate at the time the derivative was initiated. Approximately $4.3 million relates to a finance lease for a campus within our Concorde segment. The remaining $26.0 million relates to funds drawn from the $125.0 million Revolving Credit Facility that was initially secured in connection with the Concorde acquisition. See Note 10 of the notes to the condensed consolidated financial statements herein for additional details on the term loans and the Revolving Credit Facility.

Dividends

We currently do not pay a cash dividend on our common stock.

Principal Sources of Liquidity

Our principal source of liquidity is operating cash flows and existing cash and cash equivalents. A majority of our revenues are derived from Title IV Programs and various veterans’ benefits programs. Federal regulations dictate the timing of disbursements of funds under Title IV Programs. Students must apply for new funding for each academic year consisting of 30-week periods. Loan funds are generally provided in two disbursements for each academic year. The first disbursement for first-time borrowers is usually received 30 days after the start of a student’s academic year, and the second disbursement is typically received at the beginning of the 16th week from the start of the student’s academic year. Under our UTI proprietary loan program, we bear all credit and collection risk and students are not required to begin repayment until six months after the student completes or withdraws from his or her program. Similarly, we bear all credit and collection risk for students paying through cash payment plans and those under retail installment contracts. These factors, together with the timing of when our students begin their programs, affect the timing and seasonality of our operating cash flow.

Surety Bonds

Each of our campuses must be authorized by the applicable state education agency in which the campus is located to operate and to grant certificates, diplomas or degrees to its students. Our campuses are subject to extensive, ongoing regulation by each of these states. Additionally, our campuses are required to be authorized by the applicable state education agencies of certain other states in which our campuses recruit students. Our insurers issue surety bonds on behalf of our campuses and admissions representatives with multiple states to maintain authorization to conduct our business. We are obligated to reimburse our insurers for any surety bonds that are paid by the insurers. As of March 31, 2025, the total face amount of these surety bonds was approximately $22.9 million.

Operating Activities

Our net cash provided by operating activities was $22.2 million for the six months ended March 31, 2025, compared to $8.3 million for the six months ended March 31, 2024.

Net income, after adjustments for non-cash items, for the six months ended March 31, 2025 provided cash of $74.1 million. The non-cash items included $16.1 million for depreciation and amortization expense, $11.3 million for amortization of right-of-use assets for operating leases, $9.6 million for provision for credit losses expense, and $3.7 million for stock-based compensation expense.

Changes in operating assets and liabilities used cash of $51.9 million primarily due to the following:

•The change in deferred revenue used cash of $17.6 million and was primarily attributable to the timing of student starts, the number of students in school and where they were at period end in relation to completion of their program at March 31, 2025 as compared to September 30, 2024.

•The change in receivables used cash of $11.3 million and was primarily due to the timing of Title IV disbursements and other cash receipts on behalf of our students.

•The change in our operating lease liabilities used cash of $11.2 million primarily as a result of rent payments.

•The change in prepaid expenses and other current assets used cash of $4.3 million primarily due to the timing of payments.

Table of Contents

•The change in income tax payable/receivable provided cash of $3.9 million primarily due to the timing of tax payments.

•The change in notes receivable used cash of $3.8 million primarily due to higher utilization of UTI’s proprietary loan program.

•The change in other assets used cash of $3.4 million and was primarily attributable to the increase in notes receivable related to retail installment contracts.

•The change in accounts payable and accrued expenses used cash of $3.3 million primarily related to the timing of payments to vendors and for payroll and bonus accruals.

Net income, after adjustments for non-cash items, for the six months ended March 31, 2024 provided cash of $50.5 million. The non-cash items included $14.2 million for depreciation and amortization expense, $11.0 million for amortization of right-of-use assets for operating leases, $3.8 million for stock-based compensation expense, and $3.2 million for provision for credit losses.

Changes in operating assets and liabilities used cash of $42.2 million primarily due to the following:

•The change in deferred revenue used cash of $18.1 million and was primarily attributable to the timing of student starts, the number of students in school and where they were at period end in relation to completion of their program at March 31, 2024 as compared to September 30, 2023.

•Changes in our operating lease liability, primarily as a result of rent payments, used cash of $10.1 million.

•The increase in prepaid expenses used cash of $4.5 million primarily due to the timing of payments.

•The increase in notes receivable used cash of $4.4 million primarily due to higher utilization of the Tuition Loan Program.

Investing Activities

During the six months ended March 31, 2025, cash used in investing activities was $54.0 million, which included the purchase of held-to-maturity investments of $39.7 million and the purchase of property and equipment of $14.3 million to support new campus and program expansions at both UTI and Concorde.

During the six months ended March 31, 2024, cash used in investing activities was $9.8 million for the purchase of property and equipment to support new program expansion at both UTI and Concorde.

Financing Activities

During the six months ended March 31, 2025, cash used in financing activities was $35.1 million which was primarily related to $30.0 million in payments on the Revolving Credit Facility. Other uses of cash included payroll taxes paid for stock-based compensation through shares withheld of $4.5 million, and the repayment of long-term debt of $1.3 million, offset by $0.7 million related to proceeds of from stock option exercises.

During the six months ended March 31, 2024, cash used in financing activities was $35.0 million which was primarily related to $19.0 million in net payments on the revolving credit facility, or $39.0 million in payments offset by $20.0 million in proceeds. Additionally, $11.5 million was used to repurchase Series A Preferred Stock. Other uses of cash included payroll taxes paid for stock-based compensation through shares withheld of $2.1 million, the payment of long-term debt of $1.2 million, and the payment of preferred dividends of $1.1 million.

Seasonality and Trends

Our operating results normally fluctuate as a result of seasonal variations in our business, principally due to changes in the total student population and costs associated with opening or expanding our campuses. Our student population varies as a result of new student enrollments, graduations and student attrition. Historically, UTI has had lower student populations in the third quarter than in the remainder of the year because fewer students are enrolled during the summer months. Additionally, UTI has had higher student populations in the fourth quarter than in the remainder of the year because more students enroll during this period. Concorde typically has higher student populations in January and August through October for its core programs and in February for its clinical programs. UTI and Concorde core program expenses do not vary

Table of Contents

significantly with changes in student population and revenues. Concorde clinical program expenses fluctuate based on the academic calendar and season due to the timing of clinical starts. We expect quarterly fluctuations in operating results to continue as a result of seasonal enrollment patterns. However, such patterns may change as a result of new school openings, new program introductions, increased enrollments of adult students or acquisitions.

Critical Accounting Policies and Estimates

The preparation of financial statements and related disclosures in conformity with GAAP and management’s discussion and analysis of our financial condition and operating results require management to make judgments, assumptions and estimates that affect the amounts reported. There were no significant changes in our critical accounting policies and estimates in the six months ended March 31, 2025 from those previously disclosed in Part II, Item 7 of our 2024 Annual Report on Form 10-K.

Recent Accounting Pronouncements

For information regarding recent accounting pronouncements, see Note 3 of the notes to the condensed consolidated financial statements herein.

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes in our market risk exposure during the six months ended March 31, 2025. For a discussion of our exposure to market risk, refer to Part II Item 7A. “Quantitative and Qualitative Disclosures About Market Risk” contained in our 2024 Annual Report on Form 10-K.

Item 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), pursuant to Exchange Act Rule 13a-15 as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2025 to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Exchange Act Rule 13a-15(d) or 15d-15(d) that occurred during the three months ended March 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

Our management, including our Chief Executive Officer and our Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls over financial reporting will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, misstatements, errors and instances of fraud, if any, within our company have been or will be prevented or detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls also can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks that internal controls

Table of Contents

may become inadequate as a result of changes in conditions, or through the deterioration of the degree of compliance with policies or procedures.

Table of Contents

PART II. OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

In the ordinary conduct of our business, we are periodically subject to lawsuits, demands in arbitration, investigations, regulatory proceedings or other claims, including, but not limited to, claims involving current and former students, routine employment matters, business disputes and regulatory demands. When we are aware of a claim or potential claim, we assess the likelihood of any loss or exposure. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, we would accrue a liability for the loss. When a loss is not both probable and estimable, we do not accrue a liability. Where a loss is not probable but is reasonably possible, including if a loss in excess of an accrued liability is reasonably possible, we determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claim. Because we cannot predict with certainty the ultimate resolution of the legal proceedings (including lawsuits, investigations, regulatory proceedings or claims) asserted against us, it is not currently possible to provide such an estimate. The ultimate outcome of pending legal proceedings to which we are a party may have a material adverse effect on our business, cash flows, results of operations or financial condition.

Item 1A. RISK FACTORS

In addition to the other information set forth in this Quarterly Report on Form 10-Q, including the information contained in Part I, Item 3, you should carefully consider the factors discussed in Part I, Item 1A of our 2024 Annual Report on Form 10-K, which could materially affect our business, financial condition or operating results. There have been no material changes to the risk factors disclosed in Part I, Item 1A of our 2024 Annual Report on Form 10-K. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or operating results.

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

Item 3. DEFAULTS UPON SENIOR SECURITIES

None.

Item 4. MINE SAFETY DISCLOSURES

Not applicable.

Item 5. OTHER INFORMATION

(a) None.

(b) None.

(c) During the three months ended March 31, 2025, no director or officer (as defined in Rule 16a-1(f) of the Exchange Act) of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

Table of Contents

Item 6. EXHIBITS

The following exhibits required by Item 601 of Regulation S-K are filed or furnished with this report, as applicable:


Exhibit Number						Description
10.1*†						Offer Letter with Bruce Schuman dated January 27, 2025.
31.1*						Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*						Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1+						Certification of Chief Executive Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2+						Certification of Chief Financial Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*						XBRL Instance Document.
101.SCH*						XBRL Taxonomy Extension Schema Document.
101.CAL*						XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*						XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*						XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*						XBRL Taxonomy Extension Presentation Linkbase Document.
104						Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

__________________

* Filed herewith.

+ Furnished herewith.

† Indicates a management contract or any compensatory plan, contract or arrangement.

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

UNIVERSAL TECHNICAL INSTITUTE, INC.

Date:

May 8, 2025

By:

/s/ Bruce Schuman

Name:

Bruce Schuman

Title:

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

Date:

May 8, 2025

By:

/s/ Christine C.S. Kline

Name:

Christine C.S. Kline

Title:

Vice President and Chief Accounting Officer

(Principal Accounting Officer)

UNIVERSAL TECHNICAL INSTITUTE INC 10-Q